SlideShare une entreprise Scribd logo
1  sur  217
Télécharger pour lire hors ligne
Law	
  Enforcement	
  Track:	
  
Rx	
  Drug	
  Inves9ga9ons	
  in	
  the	
  
21st	
  Century	
  
Presenter:	
  Joseph	
  T.	
  Rannazzisi,	
  JD,	
  RPh,	
  
Deputy	
  Assistant	
  Administrator,	
  Office	
  of	
  
Diversion	
  Control,	
  United	
  States	
  Drug	
  
Enforcement	
  AdministraEon	
  (DEA)	
  	
  
Moderator:	
  Dan	
  Smoot,	
  CEO,	
  OperaEon	
  UNITE	
  
I	
  have	
  no	
  financial	
  rela.onships	
  to	
  disclose	
  	
  
and	
  
I	
  will	
  not	
  discuss	
  off-­‐label	
  use	
  and/or	
  
inves.ga.onal	
  drug	
  use	
  in	
  my	
  presenta.on	
  
Disclosure Statement
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
  Examine	
  reasons	
  for	
  the	
  increasing	
  rate	
  of	
  diversion	
  and	
  abuse	
  of	
  
prescrip.on	
  narco.cs	
  
  Evaluate	
  effec.ve	
  strategies	
  for	
  drug	
  diversion	
  inves.ga.ons	
  
  Describe	
  the	
  opportuni.es	
  for	
  law	
  enforcement	
  agencies	
  to	
  
collaborate	
  with	
  regulatory	
  agencies	
  during	
  drug	
  diversion	
  
inves.ga.ons	
  
Goals and Objectives
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Responding to America’s
Prescription Drug Abuse Crisis
“When Two Addictions Collide”
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
In	
  2010,	
  approximately	
  38,329	
  uninten9onal	
  drug	
  
overdose	
  deaths	
  occurred	
  in	
  the	
  United	
  States,	
  one	
  
death	
  every	
  14	
  minutes.	
  	
  
Of	
  this	
  number,	
  22,134	
  of	
  these	
  deaths	
  were	
  
aNributed	
  to	
  Prescrip9on	
  Drugs	
  (16,651	
  aNributed	
  
to	
  opioid	
  overdoses/	
  75.2	
  %).	
  	
  
Prescrip9on	
  drug	
  abuse	
  is	
  the	
  fastest	
  growing	
  drug	
  
problem	
  in	
  the	
  United	
  States.	
  
Source: CDC Drug Overdose Deaths in the United States, 2010 (October 2012)
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Consequences
U.S. Drug Overdose Deaths
by Major Drug Type, 1999-2010
Source: CDC/NCHS, NVSS
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Drug-Induced Deaths vs.
Other Injury Deaths, 1999–2009
Source: National Center for Health Statistics, Centers for Disease Control and Prevention.
National Vital Statistics Reports Deaths: Final Data for the years 1999 to 2009 (January 2012).
Causes	
  of	
  death	
  aGributable	
  to	
  drugs	
  include	
  accidental	
  or	
  inten.onal	
  poisonings	
  by	
  drugs	
  and	
  deaths	
  from	
  medical	
  condi.ons	
  resul.ng	
  from	
  chronic	
  drug	
  use.	
  	
  
Drug-­‐induced	
  causes	
  exclude	
  accidents,	
  homicides,	
  and	
  other	
  causes	
  indirectly	
  related	
  to	
  drug	
  use.	
  	
  Not	
  all	
  injury	
  cause	
  categories	
  are	
  mutually	
  exclusive.	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
2011 Current Users (Past Month) 2012
	
  	
  Source:	
  2011	
  &	
  2012	
  NSDUH	
  
Prescription Drug Abuse
More Americans abuse prescription drugs
than the number of:
Cocaine, Hallucinogen, Heroin, and Inhalant abusers
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Scope and Extent of Problem:
Past Month Illicit Drug Use among Persons
Aged 12 or Older
Source: 2004, 2007, 2008, 2009, 2010, 2011, 2012 National Survey on Drug Use and HealthU.S.	
  Drug	
  Enforcement	
  Administra.on	
  
Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Source: 2011 National Survey on
Drug Use and Health
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Percentage of Past Month Nonmedical Use
of Psychotherapeutics by Age, 2003-2011
SOURCE: 2012 National Survey on Drug Use and
Health (NSDUH) published September 2013 by the
Dept of HHS/ Substance Abuse and Mental Health
Services Administration (SAMHSA)
Past Year Initiates 2012 –
Ages 12 and Older
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Emergency Room Data 2004-2010
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
SOURCE: The DAWN Report, Highlights of the 2009 Drug Abuse Warning Network (DAWN)
Findings on Drug-Related Emergency Department Visits, December 28, 2010
SOURCE: 2012 National Survey on
Drug Use and Health (NSDUH)
published September 2013 by the
Dept of HHS/ Substance Abuse and
Mental Health Services Administration
(SAMHSA)
Substances for Which Most Recent
Treatment Was Received in the Past Year
among Persons Aged 12 or Older: 2012
SOURCE: 2012 National Survey on Drug Use and Health (NSDUH) published
September 03, 2013 by the Dept of HHS/ Substance Abuse and Mental Health Services
Administration (SAMHSA)
Substances for Which Most Recent
Treatment Was Received in the Past Year
among Persons Aged 12 or Older: 2002-2012
Number of Forensic Cases
2001-2011
0	
  
5,000	
  
10,000	
  
15,000	
  
20,000	
  
25,000	
  
30,000	
  
35,000	
  
40,000	
  
45,000	
  
50,000	
  
2001	
  2002	
  2003	
  2004	
  2005	
  2006	
  2007	
  2008	
  2009	
  2010	
  2011	
  
240%	
  	
  
257%	
  	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
322%	
  	
  
Poisoning Deaths:
Opioid Analgesics
*2009	
  data	
  approximated	
  
*	
  
Drug Overdose Mortality Rates
per 100,000 People 1999
Source: Trust for America’s Health,
www.healthyamericans.org. “Prescription Drug Abuse:
Strategies to Stop the Epidemic (2013)”
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Source: Trust for America’s Health,
www.healthyamericans.org. “Prescription Drug Abuse:
Strategies to Stop the Epidemic (2013)”
Drug Overdose Mortality Rates
per 100,000 People 2010
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
 Most severe in Southwest and Appalachian
 In 2010, the top three states were West Virginia,
New Mexico, and Kentucky;
West Virginia: 28.9 deaths per 100,000
New Mexico: 23.8 deaths per 100,000
Kentucky: 23.6 deaths per 100,000
 Lowest-North Dakota: 3.4 deaths per 100,000
 Minnesota ranked 47th 7.3 deaths per 100,000
Where Prescription Painkiller Overdose
Deaths Are The Highest
SOURCE: Trust for America’s Heath-Prescription Drug
Abuse: Strategies To Stop
The Epidemic; October 2013
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Naloxone	
  	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Source:	
  U.S.	
  Census	
  Bureau	
  
Statistical Perspective
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Why is the problem outpacing
population growth?
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
In Florida
two
Westchase
teachers
learn a
lesson:
Say 'no' to
mints in pill
bottles
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
The	
  drug	
  boGles	
  were	
  made	
  more	
  
realis.c	
  with	
  labels	
  that	
  read	
  in	
  part:	
  	
  
“Watson’s	
  Whiz	
  Kid	
  Pharmacy.	
  	
  Take	
  1	
  
tablet	
  by	
  mouth	
  EVERY	
  5	
  MINUTES	
  to	
  
cure	
  FCAT	
  jiGers.	
  	
  Repeated	
  use	
  may	
  
cause	
  crah	
  to	
  spontaneously	
  ooze	
  
from	
  pores.	
  	
  No	
  refills.	
  	
  Ms.	
  Falcon’s	
  
authoriza.on	
  required.”	
  
Violence
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Source: DEA Drug Theft & Loss Database as of 03/18/2014
Pharmacy Armed Robberies
Rankings by State
January 1 thru December 31, 2011 (691)
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Pharmacy Armed Robberies
Rankings by State
January 1 thru December 31, 2012 (780)
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Source: DEA Drug Theft & Loss Database as of 03/18/2014
Source: DEA Drug Theft & Loss Database as of 03/18/2014
Pharmacy Armed Robberies
Rankings by State
January 1 thru December 31, 2013 (692)
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
2011	
  
Violence Related to Controlled
Substance Pharmaceuticals
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
 Eyewitness	
  News	
  
	
  MEDFORD	
  (WABC)	
  -­‐-­‐	
  The	
  suspect	
  in	
  the	
  Father's	
  Day	
  massacre	
  at	
  a	
  Long	
  Island	
  
pharmacy	
  pleaded	
  guilty	
  to	
  murder	
  charges	
  Thursday.	
  	
  David	
  Laffer	
  has	
  officially	
  
withdrawn	
  his	
  not	
  guilty	
  pleas	
  to	
  charges	
  of	
  first-­‐degree	
  murder	
  and	
  criminal	
  use	
  of	
  a	
  
firearm	
  and	
  waived	
  his	
  right	
  to	
  appeal.	
  Laffer	
  killed	
  four	
  people	
  at	
  Haven	
  Drugs	
  in	
  
Medford	
  before	
  robbing	
  the	
  place	
  of	
  10,000	
  hydrocodone	
  pills.	
  	
  
	
  Laffer's	
  wife,	
  Melinda	
  Brady,	
  also	
  pleaded	
  guilty	
  to	
  robbery	
  charges.	
  The	
  judge	
  
announced	
  his	
  inten.on	
  to	
  sentence	
  Laffer	
  to	
  the	
  maximum	
  of	
  four	
  life	
  sentences	
  with	
  
no	
  parole,	
  to	
  be	
  served	
  consecu.vely,	
  and	
  Brady	
  to	
  21	
  to	
  25	
  years	
  in	
  state	
  prison.	
  
Formal	
  sentencing	
  for	
  both	
  husband	
  and	
  wife	
  is	
  scheduled	
  for	
  October	
  17.	
  	
  
	
  Laffer	
  and	
  Brady	
  were	
  arrested	
  June	
  22	
  in	
  their	
  suburban	
  home	
  a	
  mile	
  and	
  a	
  half	
  
from	
  Haven	
  Drugs,	
  where	
  authori.es	
  say	
  he	
  opened	
  fire	
  on	
  the	
  vic.ms	
  before	
  
jamming	
  the	
  backpack	
  full	
  of	
  prescrip.on	
  painkillers.	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Couple pleads guilty in
pharmacy murders
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
2 killed, 2 wounded in pharmacy shooting; ex-Bean Station officer to be
charged
By News Sentinel staff Knoxville News Sentinel
Posted May 23, 2013 at 12:28 p.m., updated May 23, 2013 at 9:52 p.m.
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Drug Education
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Where do kids get their
information from?
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
www.JustThinkTwice.com
DEA Web-based Resources
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
www.GetSmartAboutDrugs.com
DEA Web-based Resources
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
DEA Web-based Resources
www.DEA.gov
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Community	
  Coali.ons	
  and	
  
Advocacy	
  Groups	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Education
 Pharmacists	
  
	
  Drug	
  Experts	
  in	
  the	
  health	
  care	
  
	
  delivery	
  system	
  
	
  Corresponding	
  responsibility	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Scheduled	
  PDACs	
  
16-­‐Knoxville,	
  TN	
  March	
  22-­‐23,	
  2014	
  
17-­‐St.	
  Louis,	
  MO	
  April	
  5-­‐6,	
  2014	
  
18-­‐Phoenix,	
  AZ	
  June	
  28-­‐29,	
  2014	
  
19-­‐Philadelphia,	
  PA	
  July	
  12-­‐13,	
  2014	
  
20-­‐Denver,	
  CO	
  Aug	
  2-­‐3,	
  2014	
  
21-­‐Salt	
  Lake	
  City,	
  UT	
  Aug	
  23-­‐24,	
  2014	
  
	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  FL	
  
	
  2
	
  	
  	
  	
  	
  	
  	
  WA	
  
	
  	
  	
  UT
	
  	
  	
  	
  OR	
  
CA
	
  	
  NV
	
  	
  	
  	
  	
  ID	
  
	
  	
  	
  MT
	
  	
  	
  	
  	
  	
  AZ
	
  	
  WY
	
  	
  CO
	
  	
  	
  NM
ND
SD
	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  TX	
  
	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  4
NE
KS
	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  OK	
  
MN
IA
	
  	
  	
  	
  MO
AR
LA
MI
WI
	
  	
  	
  IL
IN	
  
	
  6
	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  KY
	
  	
  TN
	
  	
  	
  MS AL GA	
  
	
  	
  	
  	
  	
  	
  3
OH	
  
	
  	
  	
  	
  	
  1 	
  WV
	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  VA 	
  
	
  	
  	
  	
  	
  	
  	
  	
  NC	
  
SC
PA
	
  	
  	
  	
  	
  	
  	
  	
  	
  NY	
  
	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  5
MA
ME
DC	
  
MD	
  
NJ	
  
CT	
  
RI	
  
DE	
  
NH	
  
VT	
  
12
B
12A
18
21 20
7
11
10
17
9
14
8
16 15
13
19
Completed PDACs
	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  Scheduled PDACs
February	
  11,	
  2014	
  
Completed	
  PDACs	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  AGendance	
  
1-­‐Cincinna.,	
  OH	
  	
  9/17-­‐18/11	
  	
  	
  	
  	
  	
  	
  	
  	
   75	
  
2-­‐WPB,	
  FL	
  	
  3/17-­‐18/12	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
   1,192	
  
3-­‐Atlanta,	
  GA	
  6/2-­‐3/12	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
   328	
  
4-­‐Houston,	
  TX	
  9/8-­‐9/12	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
   518	
  
5-­‐Long	
  Island,	
  NY	
  9/15-­‐16/12	
  	
  	
  	
  	
  	
  	
   391	
  
6-­‐Indianapolis,	
  IN	
  	
  12/8-­‐9/12	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  137	
  
7-­‐Albuquerque,	
  NM	
  3/2-­‐3/13	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  284	
  
8-­‐Detroit,	
  MI	
  5/4-­‐5/13	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
   643	
  
9-­‐Chicago,	
  IL	
  	
  6/22-­‐23/13	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
   321	
  
10-­‐Portland,	
  OR	
  7/13-­‐14/13	
  	
  	
  	
  	
  	
  	
  	
  	
  	
   242	
  
11-­‐Baton	
  Rouge,	
  LA	
  	
  8/3-­‐4/13	
  	
  	
   259	
  
12A-­‐San	
  Diego,	
  CA	
  8/16-­‐17/13	
  	
  	
  	
  	
  	
   353	
  
12B-­‐San	
  Jose,	
  CA	
  8/18-­‐19/13	
  	
  	
  	
  	
  	
  	
  	
   434	
  
13-­‐Boston,	
  MA	
  9/21-­‐22/13	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
   275	
  
14-­‐Louisville,	
  KY	
  11/16-­‐17/13	
  	
  	
  	
  	
  	
  	
  	
   149	
  
15-­‐CharloGe,	
  NC	
  2/8-­‐9/14	
   513	
  
	
  	
  	
  	
  	
  	
  Total	
  AGendance	
  	
  	
   6,114	
  
Law Enforcement Sponsored
Training
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Health care
professionals
Community
associations
Most Frequent Method of
Obtaining a Pharmaceutical
Controlled Substance for Non-
Medical Use
Friends and Family…For
Free!! U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
SOURCE: 2012 National Survey on Drug Use and Health (NSDUH) published September 3, 2013 by the Dept of HHS/ Substance Abuse and Mental Health Services
Administration (SAMHSA)
Source Where Pain Relievers Were Obtained
for Most Recent Nonmedical Use Among Past
Year Users Aged 12 or Older: 2011-2012
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Medicine Cabinets: Easy Access
More than half of teens (56%) indicate that it’s easy to get
prescription drugs from their parent’s medicine cabinet
Half of parents (495) say anyone can access their medicine
cabinet
More than four in 10 teens (42%) who have misused or
abused a prescription drug obtained it from their parent’s
medicine cabinet
Almost half (49%) of teens who misuse or abuse prescription
medicines obtained them from a friend
Source: 2012 Partnership Attitude Tracking Study,
published 4/23/13
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
So Many Drugs in the
Household – Why?
Unreasonable quantities being
prescribed
Insurance rules
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Law Enforcement
Law	
  enforcement	
  officers,	
  ac9ng	
  to	
  enforce	
  laws	
  regarding	
  the	
  
abandonment	
  of	
  controlled	
  substances,	
  may	
  receive	
  controlled	
  
substances	
  from	
  ul9mate	
  users.	
  
Law	
  enforcement	
  must	
  safeguard	
  the	
  controlled	
  substances	
  and	
  
ensure	
  that	
  they	
  are	
  destroyed	
  properly.	
  
Law	
  enforcement	
  must	
  be	
  present	
  during	
  the	
  destruc9on	
  of	
  the	
  
controlled	
  substances.	
  	
  	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
April	
  26,	
  2014	
  
National Take Back Initiative
April 26, 2014
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
10:00	
  AM	
  –	
  2:00	
  PM	
  
On September 30, 2010, approximately 122 tons
On April 30, 2011, approximately188 tons
On October 29, 2011, approximately 189 tons
On April 28, 2012, approximately 276 tons
On September 29, 2012, approximately 244 tons
On April 27, 2013, approximately 376 tons
On October 26 , 2013, approximately 324 tons
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
National Take Back Day: October 26, 2013
Total Weight Collected (pounds): 647,211 (324 Tons)
8,153	
  
10,880	
  
5,527	
  
10,030	
  
17,077	
  	
  
MA	
  
2,171	
  
RI	
  
4,603
CT	
  
16,520	
  
3,430	
  
VT	
  
5,343	
  	
  
NH	
  
811	
  
PR	
  &	
  VI	
  
33,761	
  
22,000	
  
215	
  
38,506	
  
10,402	
  
46,565	
  
936	
  
18,433	
  
1,195	
  
1,251	
  
4,461	
  
11,380	
  
23,678	
  
9,171	
  
3,215	
  
72,886	
  
1,777	
  
2,580	
  	
  
HI	
  &	
  GU	
  
	
  16,950	
  	
  
14,841
NJ	
  
2,541	
  
18,008	
  
1,420	
  
4,123	
  
41,501	
  
38,493	
  
10,303	
  
14,508	
  
5,766	
  
4,587	
  
2,763	
  
19,901	
  
7,004	
  
9,737	
  
6,194	
  
908	
  
20,072	
  
4,977	
  
9,425
MD	
  
974	
  
DC	
  
5,258	
  
DE	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Prescription drug
epidemic?
How did we get to this
point?
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
The 1960s/70s/80s
Downers	
  -­‐	
  Barbiturates	
  
Uppers	
  -­‐	
  Amphetamines	
  
Meprobamate	
  
Hydromorphone	
  
“Ts	
  and	
  Blues”	
  
“Fours	
  and	
  Doors”	
  
Oxycodone/APAP	
  
methaqualone	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
The
1990s
Hydrocodone
AlprazolamOxycodone 30 mg
Carisoprodol	
  
OxyCon.n	
  80mg	
  
Commonly Abused Controlled Pharmaceuticals
Oxymorphone	
  
C-­‐IV	
  as	
  of	
  1/11/2012	
  
The Trinity
C-­‐IV	
  as	
  of	
  1/11/2012	
  
Hydrocodone	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Most commonly prescribed prescription
medicine?
Hydrocodone/acetaminophen
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Top Five Prescription Drugs Sold in the U.S.
(2008-2011)
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Source:	
  IMS	
  	
  Health,	
  Na.onal	
  Prescrip.on	
  Audit,	
  Updated	
  02/24/14	
  
	
  	
  Millions	
  of	
  
Prescrip.ons	
  
State Ranking* - Hydrocodone
January – September 2013
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Source: Drug Enforcement Administration, Office of Diversion Control,
Pharmaceutical Investigations Section, Targeting and Analysis Unit
Most current ARCOS information as of March 18, 2014
Approval of Single Entity
Extended Release Hydrocodone
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Source: Drug Enforcement Administration, Office of Diversion Control,
Pharmaceutical Investigations Section, Targeting and Analysis Unit
Most current ARCOS information as of March 18, 2014
State Ranking* - Oxycodone
January – December 2013
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
OxyContin Change
New OxyContin® OP
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Oxycodone 15mg/30mg
Immediate Release
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Opana ER (Schedule II)
 Opana	
  ER	
  -­‐	
  (Schedule	
  II)	
  
– Treats	
  constant,	
  around	
  the	
  clock,	
  moderate	
  to	
  
severe	
  pain	
  
– Becoming	
  popular	
  and	
  is	
  abused	
  in	
  similar	
  fashion	
  
to	
  oxycodone	
  ;	
  August	
  2010	
  (Los	
  Angeles	
  FD	
  TDS)	
  
– Slang:	
  Blues,	
  Mrs.	
  O,	
  Octagons,	
  Stop	
  Signs,	
  Panda	
  
Bears	
  
– Street:	
  	
  $10.00	
  –	
  $80.00	
  	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Source: Drug Enforcement Administration, Office of Diversion Control,
Pharmaceutical Investigations Section, Targeting and Analysis Unit
Most current ARCOS information as of March 18, 2014
State Ranking* - Oxymorphone
January – December 2013
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Hydromorphone
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Source: Drug Enforcement Administration, Office of Diversion Control,
Pharmaceutical Investigations Section, Targeting and Analysis Unit
Most current ARCOS information as of March 18, 2014
State Ranking* - Hydromorphone
January – December 2013
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Opiates v. Heroin
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Circle of Addiction & the Next Generation
Hydrocodone	
  
Lorcet®	
  
$5-­‐$7/tab	
  
Oxycodone	
  
Combina.ons	
  
Percocet®	
  
$7-­‐$10/tab	
  
OxyCon9n®	
  
$80/tab	
  
Heroin	
  
	
  	
  	
  	
  	
  	
  $10/bag	
  
Roxicodone®	
  
Oxycodone	
  IR	
  
15mg,	
  30mg	
  
$30-­‐$40/tab	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
HEROIN CASES and EXHIBITS
National Forensic Laboratory Information System
Year	
   #	
  Exhibits	
   #	
  Cases	
  
2004	
   69,467	
   60,851	
  
2005	
   73,569	
   64,471	
  
2006	
   83,945	
   72,351	
  
2007	
   82,408	
   69,850	
  
2008	
   94,229	
   79,366	
  
2009	
   107,272	
   87,249	
  
2010	
   104,676	
   84,170	
  
2011	
   109,049	
   86,513	
  
2012	
   127,568	
   101,512	
  
2013:	
  Jan	
  –	
  Jun	
   69,574	
   55,325	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Heroin	
  trafficking	
  organiza.ons	
  reloca.ng	
  to	
  areas	
  where	
  
prescrip.on	
  drug	
  abuse	
  is	
  on	
  the	
  rise	
  
Heroin	
  traffickers	
  pave	
  the	
  way	
  for	
  increasing	
  crime	
  and	
  
violence	
  
Law	
  enforcement	
  and	
  prosecutors	
  eventually	
  figh.ng	
  the	
  
problem	
  on	
  two	
  fronts	
  (prescrip.on	
  opiate	
  diversion	
  and	
  
heroin	
  distribu.on)	
  further	
  deple.ng	
  resources	
  
Communi.es	
  suffer	
  
Community Impact?
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Where are the
Pharmaceuticals Coming
From?
 Friends	
  and	
  Family	
  for	
  Free	
  
 Medicine	
  Cabinet	
  
 Doctor	
  Shopping	
  
 Internet	
  
 Pain	
  Clinics	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Methods of Diversion
 Practitioners / Pharmacists
–  Illegal distribution
–  Self abuse
–  Trading drugs for sex
 Employee pilferage
–  Hospitals
–  Practitioners’ offices
–  Nursing homes
–  Retail pharmacies
–  Manufacturing / distribution
facilities
 Pharmacy / Other Theft
–  Armed robbery
–  Burglary (Night Break-ins)
–  In Transit Loss (Hijacking)
–  Smurfing
 Patients / Drug Seekers
–  Drug rings
–  Doctor-shopping
–  Forged / fraudulent / altered
prescriptions
 The medicine cabinet / obituaries
 The Internet
 Pain Clinics
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Prescription Fraud
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Questions to Discuss
 	
  What	
  combina.on	
  of	
  drugs	
  is	
  referred	
  to	
  as	
  the	
  “trinity”?	
  
	
  	
  	
  A)	
  	
  Hydrocodone,	
  alprazolam,	
  and	
  carisoprodol	
  
	
  	
  	
  B)	
  	
  Promethazine	
  with	
  codeine,	
  methylphenidate	
  and	
  
	
  	
  	
  	
  	
  	
  	
  	
  carisoprodol	
  
	
  	
  	
  C)	
  	
  Hydromorphone,	
  carisoprodol	
  and	
  buprenorphine	
  
	
  	
  	
  D)	
  	
  Methadone,	
  diazepam	
  and	
  tramadol	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Doctor Shopping
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Prescription Drug Monitoring
Programs
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Mandatory PDMP review before
prescribing CS?
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Standard of Care
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
National Association of
Boards of Pharmacy
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Diversion via the
Internet
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
WA
OR
ID
WY
ND
SD
MN
NE
WI
MI
CO
KS MO
IL IN
UT
NV
CA
AZ NM
OK
AR
LA
TN
KY
MS AL GA
SC
NC
OH
VA
PA
NY
ME
V
T N
H
CT
DE
WV
RI
MD
MA
Domestic ‘Rx’ Flow
MTMT
FL
TX TX
2. Request goes
through Website
Server in
San Antonio, TX
WS
FL
IAIA NJ
1. Consumer in Montana
orders hydrocodone
on the Internet
C
3. Web Company
(located in Miami, FL)
adds request to queue
for Physician approval
WC
4. Order is
approved by
Physician in
New Jersey
and returned
to Web
Company
Dr.
S
6. Pharmacy in Iowa
fills order and ships to
Consumer via Shipper
Rx
5. Approved
order
then sent by
Web
Company
to an
affiliated
Pharmacy
New Felony Offense Internet
Trafficking - 10/15/2008	
  
  21 USC 841(h)(1): It shall be unlawful for any
person to knowingly or intentionally:
(A) deliver, distribute, or dispense a controlled
substance by means of the Internet, except as
authorized by this title; or
(B) aid or abet any violation in (A)
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Per Se Violations
 No in-person medical evaluation by
prescribing practitioner
 Online pharmacy not properly registered
with modified registration.
 Website fails to display required information
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Pain Clinics
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Explosion of South Florida
Pain Clinics
As	
  of	
  June	
  4,	
  2010,	
  Florida	
  has	
  received	
  1,118	
  applica.ons	
  and	
  has	
  approved	
  1026	
  
*As	
  of	
  May	
  14,	
  2010,	
  Broward	
  142;	
  Miami-­‐Dade	
  79;	
  Palm	
  Beach	
  111	
  	
  U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Hydrocodone Oxycodone
2002 9,376 8,288
2003 12,130 9,715
2004 16,401 13,492
2005 21,190 14,643
2006 24,984 17,927
2007 30,637 22,425
2008 33,731 28,756
2009 38,084 38,332
2010 39,444 48,210
2011 37,483 46,906
2012 35,140 42,869
2013* 26,844 31,897
NFLIS – Federal, State, and local cases reported
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
NFLIS	
  Query	
  Date:	
  02/24/14	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Medical Care ?
 Many	
  of	
  these	
  clinics	
  are	
  prescrip.on/
dispensing	
  mills	
  
 Minimal	
  prac..oner/pa.ent	
  interac.on	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Increased Law Enforcement
Pressure
 Clinics	
  migra.ng	
  north	
  and	
  west	
  
 Funded	
  by	
  owners	
  in	
  Florida	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
WASHINGTON
OREGON
CALIFORNIA
NEVADA
IDAHO
MONTANA
WYOMING
UTAH
ARIZONA NEW MEXICO
COLORADO
TEXAS
OKLAHOMA
KANSAS
NEBRASKA
SOUTH DAKOTA
NORTH DAKOTA
MINNESOTA
IOWA
MISSOURI
ARKANSAS
LOUIS.
MISS.
ALA.
GEORGIA
FLA.
WISC. MICH.
ILL.
IND.
OHIO
PENN.
N.Y.
MAINE
R.I.
CONN.
N.J.
N.H.
VT.
MASS.
W.V.
DEL.
MD.
S.C.
VIRGINIA
N.C.
KENTUCKY
TENN.
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
WASHINGTON
OREGON
CALIFORNIA
NEVADA
IDAHO
MONTANA
WYOMING
UTAH
ARIZONA NEW MEXICO
COLORADO
TEXAS
OKLAHOMA
KANSAS
NEBRASKA
SOUTH DAKOTA
NORTH DAKOTA
MINNESOTA
IOWA
MISSOURI
ARKANSAS
LOUIS.
MISS.
ALA.
GEORGIA
FLA.
WISC. MICH.
ILL.
IND.
OHIO
PENN.
N.Y.
MAINE
R.I.
CONN.
N.J.
N.H.
VT.
MASS.
W.V.
DEL.
MD.
S.C.
VIRGINIA
N.C.
KENTUCKY
TENN.
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
WASHINGTON
OREGON
CALIFORNIA
NEVADA
IDAHO
MONTANA
WYOMING
UTAH
ARIZONA NEW MEXICO
COLORADO
TEXAS
OKLAHOMA
KANSAS
NEBRASKA
SOUTH DAKOTA
NORTH DAKOTA
MINNESOTA
IOWA
MISSOURI
ARKANSAS
LOUIS.
MISS.
ALA.
GEORGIA
FLA.
WISC. MICH.
ILL.
IND.
OHIO
PENN.
N.Y.
MAINE
R.I.
CONN.
N.J.
N.H.
VT.
MASS.
W.V.
DEL.
MD.
S.C.
VIRGINIA
N.C.
KENTUCKY
TENN.
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
WASHINGTON
OREGON
CALIFORNIA
NEVADA
IDAHO
MONTANA
WYOMING
UTAH
ARIZONA NEW MEXICO
COLORADO
TEXAS
OKLAHOMA
KANSAS
NEBRASKA
SOUTH DAKOTA
NORTH DAKOTA
MINNESOTA
IOWA
MISSOURI
ARKANSAS
LOUIS.
MISS.
ALA.
GEORGIA
FLA.
WISC. MICH.
ILL.
IND.
OHIO
PENN.
N.Y.
MAINE
R.I.
CONN.
N.J.
N.H.
VT.
MASS.
W.V.
DEL.
MD.
S.C.
VIRGINIA
N.C.
KENTUCKY
TENN.
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
WASHINGTON
OREGON
CALIFORNIA
NEVADA
IDAHO
MONTANA
WYOMING
UTAH
ARIZONA NEW MEXICO
COLORADO
TEXAS
OKLAHOMA
KANSAS
NEBRASKA
SOUTH DAKOTA
NORTH DAKOTA
MINNESOTA
IOWA
MISSOURI
ARKANSAS
LOUIS.
MISS.
ALA.
GEORGIA
FLA.
WISC. MICH.
ILL.
IND.
OHIO
PENN.
N.Y.
MAINE
R.I.
CONN.
N.J.
N.H.
VT.
MASS.
W.V.
DEL.
MD.
S.C.
VIRGINIA
N.C.
KENTUCKY
TENN.
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
WASHINGTON
OREGON
CALIFORNIA
NEVADA
IDAHO
MONTANA
WYOMING
UTAH
ARIZONA NEW MEXICO
COLORADO
TEXAS
OKLAHOMA
KANSAS
NEBRASKA
SOUTH DAKOTA
NORTH DAKOTA
MINNESOTA
IOWA
MISSOURI
ARKANSAS
LOUIS.
MISS.
ALA.
GEORGIA
FLA.
WISC. MICH.
ILL.
IND.
OHIO
PENN.
N.Y.
MAINE
R.I.
CONN.
N.J.
N.H.
VT.
MASS.
W.V.
DEL.
MD.
S.C.
VIRGINIA
N.C.
KENTUCKY
TENN.
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
WASHINGTON
OREGON
CALIFORNIA
NEVADA
IDAHO
MONTANA
WYOMING
UTAH
ARIZONA NEW MEXICO
COLORADO
TEXAS
OKLAHOMA
KANSAS
NEBRASKA
SOUTH DAKOTA
NORTH DAKOTA
MINNESOTA
IOWA
MISSOURI
ARKANSAS
LOUIS.
MISS.
ALA.
GEORGIA
FLA.
WISC. MICH.
ILL.
IND.
OHIO
PENN.
N.Y.
MAINE
R.I.
CONN.
N.J.
N.H.
VT.
MASS.
W.V.
DEL.
MD.
S.C.
VIRGINIA
N.C.
KENTUCKY
TENN.
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
WASHINGTON
OREGON
CALIFORNIA
NEVADA
IDAHO
MONTANA
WYOMING
UTAH
ARIZONA NEW MEXICO
COLORADO
TEXAS
OKLAHOMA
KANSAS
NEBRASKA
SOUTH DAKOTA
NORTH DAKOTA
MINNESOTA
IOWA
MISSOURI
ARKANSAS
LOUIS.
MISS.
ALA.
GEORGIA
FLA.
WISC. MICH.
ILL.
IND.
OHIO
PENN.
N.Y.
MAINE
R.I.
CONN.
N.J.
N.H.
VT.
MASS.
W.V.
DEL.
MD.
S.C.
VIRGINIA
N.C.
KENTUCKY
TENN.
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
WASHINGTON
OREGON
CALIFORNIA
NEVADA
IDAHO
MONTANA
WYOMING
UTAH
ARIZONA NEW MEXICO
COLORADO
TEXAS
OKLAHOMA
KANSAS
NEBRASKA
SOUTH DAKOTA
NORTH DAKOTA
MINNESOTA
IOWA
MISSOURI
ARKANSAS
LOUIS.
MISS.
ALA.
GEORGIA
FLA.
WISC. MICH.
ILL.
IND.
OHIO
PENN.
N.Y.
MAINE
R.I.
CONN.
N.J.
N.H.
VT.
MASS.
W.V.
DEL.
MD.
S.C.
VIRGINIA
N.C.
KENTUCKY
TENN.
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Drugs Prescribed
 A	
  ‘cocktail’	
  of	
  oxycodone	
  and	
  alprazolam	
  (Xanax)	
  
 An	
  average	
  ‘pa.ent’	
  receives	
  prescrip.ons	
  or	
  
medica.ons	
  in	
  combina.on	
  
Schedule	
  II	
   Schedule	
  III	
   Schedule	
  IV	
  
Oxycodone	
  15mg,	
  30mg	
   Vicodin	
  (Hydrocodone)	
   Xanax	
  (Alprazolam)	
  
Roxicodone	
  15mg,	
  30mg	
  	
   Lorcet	
   Valium	
  (Diazepam)	
  
Percocet	
   Lortab	
  
Percodan	
   Tylenol	
  #3	
  (codeine)	
  
Demerol	
   Tylenol	
  #4	
  (codeine)	
  
Methadone	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Average Charges for a Clinic Visit
 Price varies if medication is dispensed or if customers
receive prescriptions
 Some clinics advertise in alternative newspapers
citing discounts for new patients such as 'buy one get
one free‘ or “50% off with this ad”
 Typically, initial office visit is $250 or more; each
subsequent visit may exceed $200
 Prescriptions average 120-180 30mg oxycodone
tablets per visit
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Cost of Drugs
 According	
  to	
  medical	
  experts,	
  most	
  clinics	
  do	
  not	
  
require	
  sufficient	
  medical	
  history	
  and	
  tests	
  for	
  proper	
  
prescribing	
  of	
  Schedule	
  II	
  substances	
  
 Oxycodone	
  30mg	
  immediate	
  release	
  tablets	
  cost	
  	
  
approximately	
  $30.00	
  to	
  $40.00	
  per	
  tablet	
  on	
  the	
  street	
  
depending	
  on	
  the	
  sale	
  loca.on	
  in	
  the	
  U.S.	
  ($1	
  per	
  mg	
  or	
  
more)	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
What’s the Profit?
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
What’s the Profit?
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
What’s the Profit?
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Florida
Pain
Clinic Raid
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
The	
  Controlled	
  Substances	
  Act	
  	
  
Foreign Mfr
Importer Manufacturer
Distri-
butor
Practitioner
Pharmacy
Hospital
Clinic
Patient
?
Law:	
  21	
  USC	
  822	
  	
  (a)	
  (1)	
  Persons	
  Required	
  to	
  Register:	
  
“Every	
  person	
  who	
  manufactures	
  or	
  distributes	
  any	
  Controlled	
  Substance	
  or	
  List	
  I	
  
Chemical	
  or	
  who	
  proposes	
  to	
  engage	
  in	
  ..”	
  
Law:	
  21	
  USC	
  822	
  (a)	
  (2)	
  Persons	
  Required	
  to	
  Register:	
  
“Every	
  person	
  who	
  dispenses,	
  or	
  who	
  proposes	
  to	
  dispense	
  any	
  	
  
controlled	
  substance	
  ...”	
  
Closed System
of Distribution
Cyclic
Investigations
Security
Requirements
Recordkeeping
Requirements
ARCOS
Established
Quotas
Registration
Established
Schedules
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
150	
   U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
The Flow of Pharmaceuticals
PATIENTS
Hospitals NTPs
21 CFR 1306.04
Physicians
(Rx and drugs)
Pharmacies
QUOTASRaw Material
Importers Imp - Manufacturers
21 USC 823(c)(1)
21 USC 823(d)(1)
21 CFR 1301.71
Dosage Form
Manufacturers
Manufacturers
Dosage Form
Manufacturers
21 USC 823(b)(1)
21 USC 823(e)(1)
21 CFR 1301.71
21 CFR 1301.74
(Suspicious Orders)
Wholesalers - DistributorsSmaller Distributors
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Diversion via the
Internet
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
WA
OR
ID
WY
ND
SD
MN
NE
WI
MI
CO
KS MO
IL IN
UT
NV
CA
AZ NM
OK
AR
LA
TN
KY
MS AL GA
SC
NC
OH
VA
PA
NY
ME
V
T N
H
CT
DE
WV
RI
MD
MA
Domestic ‘Rx’ Flow
MTMT
FL
TX TX
2. Request goes
through Website
Server in
San Antonio, TX
WS
FL
IAIA NJ
1. Consumer in Montana
orders hydrocodone
on the Internet
C
3. Web Company
(located in Miami, FL)
adds request to queue
for Physician approval
WC
4. Order is
approved by
Physician in
New Jersey
and returned
to Web
Company
Dr.
S
6. Pharmacy in Iowa
fills order and ships to
Consumer via Shipper
Rx
5. Approved
order
then sent by
Web
Company
to an
affiliated
Pharmacy
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Purchases of hydrocodone by Known and Suspected
Rogue Internet Pharmacies
January 1, 2006 – December 31, 2006
Date	
  Prepared:	
  	
  	
  03/07/2007	
  Source:	
  	
  ARCOS	
  
98,566,711
Checks and Balances of the CSA
and the Regulatory Scheme
  Distributors of controlled substances
“The registrant shall design and operate a system to
disclose to the registrant suspicious orders of
controlled substances…Suspicious orders include
orders of unusual size, orders deviating
substantially from a normal pattern, and orders of
unusual frequency.” (21 CFR §1301.74)
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
DEA	
  Distributor	
  Ini9a9ve	
  
  Purpose and format:
  Educate and inform distributors/manufacturers of their due diligence
responsibilities under the CSA by discussing their Suspicious Order Monitoring
System, reviewing their ARCOS data for sales and purchases of Schedules II and
III controlled substances, and discussing national trends involving the abuse of
prescription controlled substances
  August 2005 – Present:
Briefings to 83 firms with 276 locations
Examples of civil action against distributors:
Cardinal Health , $34 million civil fine
McKesson, $13.25 million civil fine
Harvard, $6 million civil fine
Examples of suspension, surrender or revocation of DEA registration
Keysource, loss of DEA registration
Sunrise, loss of DEA registration U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Source:	
  www.kuow.org	
  ,	
  
01/30/2014	
  
John Gray, president and CEO of
Healthcare Distribution
Management Association, said
suppliers used to have a more
cooperative and collaborative
relationship with the Drug
Enforcement Agency. But things
have changed, he said. “It’s all
been dumped in our laps as
wholesalers to make what I
would consider to be law
enforcement decisions as to
whether or not a particular
customer or account is or is not
over what the DEA, in their own
mind, thinks is a viable limit for
Schedule II drugs they ought to
be dispensing,” Gray said.
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
“At	
  the	
  .me	
  we	
  filled	
  these	
  orders,	
  the	
  pharmacies	
  held	
  valid	
  state	
  	
  
board	
  of	
  pharmacy	
  and	
  DEA	
  licenses,”	
  BarreG	
  said	
  in	
  a	
  call	
  to	
  investors	
  on	
  
Friday.	
  “Pharmaceu.cal	
  distributors	
  do	
  not	
  influence	
  the	
  manufacture	
  of	
  
controlled	
  medicines.	
  We	
  do	
  not	
  write	
  prescrip.ons.	
  We	
  do	
  not	
  dispense	
  
controlled	
  medicines,	
  nor	
  do	
  we	
  license	
  pharmacies.	
  Our	
  role	
  is,	
  as	
  a	
  
distributor,	
  a	
  cri.cal	
  link	
  in	
  the	
  supply	
  chain	
  between	
  pharmaceu.cal	
  
manufacturers	
  and	
  pharmacies.	
  “	
  	
  	
  Cardinal	
  CEO	
  George	
  BarreG	
  
The	
  Company	
  called	
  the	
  DEA	
  ac.on	
  	
  “a	
  dras.c	
  overreac.on”	
  
that	
  would	
  disrupt	
  delivery	
  of	
  cri.cal	
  medica.ons	
  to	
  	
  
hospitals	
  and	
  pharmacies.	
  
Misleading	
  Title?	
  
Sponsored	
  by	
  
Reps	
  from	
  TN,	
  
PA,	
  CO,	
  	
  and	
  GA	
  
This	
  bill	
  effec.vely	
  eliminates	
  the	
  DEA’s	
  
administra.ve	
  powers	
  of	
  the	
  OTSC	
  and	
  ISO	
  
op.ons,	
  and	
  instead	
  requires	
  DEA	
  to	
  give	
  
no.ce	
  and	
  offer	
  the	
  registrant	
  an	
  opportunity	
  
to	
  submit	
  a	
  correc.ve	
  ac.on	
  plan.	
  
An	
  ISO	
  is	
  issued	
  to	
  protect	
  the	
  public	
  from	
  
imminent	
  harm.	
  	
  By	
  redefining	
  an	
  ISO	
  and	
  
delaying	
  it’s	
  issuance,	
  the	
  bill	
  would	
  prevent	
  
the	
  DEA	
  from	
  protec.ng	
  the	
  public	
  when	
  harm	
  
is	
  imminent.	
  
DEA	
  conducts	
  more	
  5,000	
  inspec.ons	
  on	
  
registrants	
  yearly	
  and	
  takes	
  administra.ve	
  
ac.on	
  on	
  a	
  very	
  small	
  percentage	
  of	
  those	
  
registrants	
  inspected.	
  
DEA Imposed Quotas on Wholesalers/
Distributors of Controlled Substances to
downstream customers?
NO!
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Checks and Balances
Under the CSA
•  Practitioners
“A prescription for a controlled substance to be
effective must be issued for a legitimate medical
purpose by an individual practitioner acting in the
usual course of professional practice.” (21 CFR §1306.04
(a))
United States v Moore 423 US 122 (1975)
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
The Controlled Substances Act
Illegal Distribution
21 U.S.C. § 841 (a) Unlawful acts:
Except as authorized by this subchapter, it shall be
unlawful for any person to knowingly or
intentionally
(1) to manufacture, distribute or dispense, or
possess with intent to manufacture, distribute or
dispense, a controlled substance; or
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
The Last Line of Defense
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Checks and Balances
Under the CSA
Pharmacists – The Last Line of Defense
“The responsibility for the proper prescribing and
dispensing of controlled substances is upon the
practitioner, but a corresponding responsibility rests
with the pharmacist who fills the prescription.”
(21 CFR §1306.04(a))
U.S v. Hayes 595 F. 2d 258 (5th Cir 1979)
U.S. v. Leal 75 F. 3d 219 (6th Cir 1996)
U.S. v. Birbragher 603 F. 3d 478 (8th Cir 2010)
East Main Street Pharmacy 75 Fed. Reg. 66149 (Oct. 27,
2010)
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Checks and Balances Under the CSA
Pharmacists – The Last Line of Defense
“An order purporting to be a prescription issued not in the
course of professional treatment or in legitimate and authorized
research is not a prescription within the meaning and intent of
section 309 of the act (21 USC 829) and the person knowingly
filling such a purported prescription, as well as the person
issuing it, shall be subject to the penalties provided for violations
of the provisions of law relating to controlled substances.” (21
CFR §1306.04(a))
U.S v. Hayes 595 F. 2d 258 (5th Cir 1979)
U.S. v. Leal 75 F. 3d 219 (6th Cir 1996)
U.S. v. Birbragher 603 F. 3d 478 (8th Cir 2010)
East Main Street Pharmacy 75 Fed. Reg. 66149 (Oct. 27, 2010)
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
 When	
  prescrip.ons	
  are	
  clearly	
  not	
  
issued	
  for	
  legi.mate	
  medical	
  purposes,	
  a	
  
pharmacist	
  may	
  not	
  inten.onally	
  close	
  his	
  
eyes	
  and	
  thereby	
  avoid	
  [actual]	
  knowledge	
  
of	
  the	
  real	
  purpose	
  of	
  the	
  prescrip.ons.	
  	
  
(Ralph	
  J.	
  Bertolino,	
  55	
  FR	
  4729,	
  4730	
  
(1990)),	
  	
  
Corresponding Responsibility Cases
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
What	
  happens	
  next?	
  
You	
  aGempt	
  to	
  resolve…	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Resolution is comprised of many
factors
Verifica.on	
  of	
  a	
  valid	
  prac..oner	
  DEA	
  number	
  	
  is	
  required!	
  	
  It	
  is	
  not,	
  
however,	
  the	
  end	
  of	
  the	
  pharmacists	
  duty.	
  	
  Invalid	
  RX	
  
Resolu.on	
  cannot	
  be	
  based	
  solely	
  on	
  pa.ent	
  ID	
  and	
  prescriber	
  
verifica.on.	
  	
  	
  
You	
  must	
  use	
  your	
  professional	
  	
  judgment,	
  training	
  and	
  experience…we	
  
all	
  make	
  mistakes	
  
Knowledge	
  	
  and	
  history	
  with	
  the	
  pa.ent	
  
Circumstances	
  of	
  prescrip.on	
  presenta.on	
  
Experience	
  with	
  the	
  prescribing	
  prac..oner	
  
It	
  does	
  not	
  require	
  a	
  call	
  to	
  the	
  prac..oner	
  for	
  every	
  CS	
  RX	
  
This	
  is	
  not	
  an	
  all-­‐inclusive	
  list…	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Many	
  customers	
  receiving	
  the	
  same	
  combina.on	
  of	
  prescrip.ons;	
  cocktail	
  
Many	
  customers	
  receiving	
  the	
  same	
  strength	
  of	
  controlled	
  substances;	
  no	
  
individualized	
  dosing:	
  mul.ple	
  prescrip.ons	
  for	
  the	
  strongest	
  dose	
  
Many	
  customers	
  paying	
  cash	
  for	
  their	
  prescrip.ons	
  
Early	
  refills	
  
Many	
  customers	
  with	
  the	
  same	
  diagnosis	
  codes	
  wriGen	
  on	
  their	
  prescrip.ons;	
  
Individuals	
  driving	
  long	
  distances	
  to	
  visit	
  physicians	
  and/or	
  to	
  fill	
  prescrip.ons;	
  	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Customers	
  coming	
  into	
  the	
  pharmacy	
  in	
  groups,	
  each	
  with	
  the	
  same	
  
prescrip.ons	
  issued	
  by	
  the	
  same	
  physician;	
  and	
  
Customers	
  with	
  prescrip.ons	
  for	
  controlled	
  substances	
  wriGen	
  by	
  physicians	
  not	
  
associated	
  with	
  pain	
  management	
  (i.e.,	
  pediatricians,	
  gynecologists,	
  
ophthalmologists,	
  etc.).	
  
Overwhelming	
  propor.on	
  of	
  prescrip.ons	
  filled	
  by	
  pharmacy	
  are	
  controlled	
  
substances	
  
Pharmacist	
  did	
  not	
  reach	
  out	
  to	
  other	
  pharmacists	
  to	
  determine	
  why	
  they	
  were	
  
not	
  filling	
  a	
  par.cular	
  doctors	
  prescrip.on	
  
Verifica.on	
  of	
  legi.macy	
  not	
  sa.sfied	
  by	
  a	
  call	
  to	
  the	
  doctors	
  office	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
AMA View on Corresponding
Responsibility
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Inquiries	
  by	
  pharmacists	
  with	
  doctors	
  regarding	
  the	
  ra.onale	
  behind	
  	
  	
  	
  
prescrip.ons,	
  diagnoses	
  	
  and	
  treatment	
  plans	
  are	
  inappropriate.	
  
	
  These	
  inquiries	
  are	
  
“an	
  interference	
  with	
  the	
  prac.ce	
  of	
  medicine	
  and	
  unwarranted”.	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Purchases of Oxycodone 30mg
 In	
  2009,	
  	
  44%	
  of	
  all	
  oxycodone	
  30mg	
  products	
  
were	
  distributed	
  to	
  Florida	
  
 In	
  2010,	
  	
  43%	
  of	
  all	
  oxycodone	
  30mg	
  products	
  
were	
  distributed	
  to	
  Florida	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Remaining	
  States	
  
593,625,290	
  dosage	
  units	
   Florida	
  
94,923,484	
  dosage	
  units	
  
Source:	
  	
  ARCOS	
  	
  
Date	
  Prepared:	
  	
  	
  01/30/2014	
   U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Florida	
  
94,923,484	
  dosage	
  units	
  
New	
  York	
  
50,658,100	
  dosage	
  
units	
  
Remaining	
  States	
  
486,977,390	
  dosage	
  units	
  
California	
  
55,989,800	
  dosage	
  
units	
  
Source:	
  	
  ARCOS	
  	
  
Date	
  Prepared:	
  	
  	
  01/30/2014	
   U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Viola.ons?	
  
What	
  happens	
  next…..	
  
DEA Legal Recourse
 Administra.ve	
  
	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  Immediate	
  Suspension	
  Order	
  (ISO)	
  
	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  Memorandum	
  of	
  Agreement	
  (MOA)	
  
	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  Order	
  to	
  Show	
  Cause	
  (OTSC)	
  
 Civil	
  
	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  Fines	
  
 Criminal	
  
	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  	
  Tac.cal	
  Diversion	
  Squads	
  	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
How Do You Lose Your
Registration?
The	
  Order	
  to	
  Show	
  Cause	
  Process	
  
	
  21	
  USC	
  §	
  824	
  
a)  Grounds	
  –	
  	
  
1.  Falsifica.on	
  of	
  Applica.on	
  
2.  Felony	
  Convic.on	
  
3.  State	
  License	
  or	
  Registra.on	
  suspended,	
  revoked	
  or	
  denied	
  –	
  
no	
  longer	
  authorized	
  by	
  State	
  law	
  
4.  Inconsistent	
  with	
  Public	
  Interest	
  
5.  Excluded	
  from	
  par.cipa.on	
  in	
  Title	
  42	
  USC	
  §	
  1320a-­‐7(a)	
  
program	
  
b)	
  	
  	
  	
  AG	
  discre.on,	
  may	
  suspend	
  any	
  registra.on	
  simultaneously	
  
with	
  Order	
  to	
  Show	
  Cause	
  upon	
  a	
  finding	
  of	
  Imminent	
  Danger	
  to	
  
Public	
  Health	
  and	
  Safety	
  	
  
* FY2014 as of February 27, 2014
AdministrativeActions Initiated by DEA
FY2007thru2014*
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Initiation of Investigation
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
ARCOS
PDMP	
  	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
 Inves9ga9ng	
  Physicians	
  
• “Outside the Scope”
–  CFR and Case Law: “A prescription for a controlled
substance to be effective must be issued for a legitimate
medical purpose by an individual practitioner acting in
the usual course of his professional practice.”
–  “In accordance with the standard of medical practice
generally recognized and accepted in the US.”
Once outside the scope => 21 USC 841
U.S. Drug Enforcement Administration / Operations Division / Office of Diversion Control
Legal Basis
Standards	
  of	
  Care-­‐State	
  Boards	
  
U.S. Drug Enforcement Administration / Operations Division / Office of Diversion Control
Inves9ga9ng	
  Physicians	
  
Targeting sources:
–  Referrals from medical/pharmacy boards
–  Law enforcement agency partners
–  Confidential Sources
–  Liaison:
•  Hospitals (ER staff)
•  Medical examiners
•  Treatment /Rehab facilities
•  Pharmacies (PICs and security staff)
–  Choicepoint and other commercially available databases
U.S. Drug Enforcement Administration / Operations Division / Office of Diversion Control
Targeting/Evaluation
Interviews of sources (patients, former employees)
–  Look for Patterns and RED FLAGS:
•  Relatively large quantities of controlled substances
•  Little or no medical exam or diagnostic exams
•  Cash-only practice
•  No referrals to specialist for treatment or evaluation
•  Pain “cocktails”
•  Patients live long distances from practice
•  Long lines of waiting patients
•  Patients show indications of addiction
•  Directed patients to specific pharmacies
U.S. Drug Enforcement Administration / Operations Division / Office of Diversion Control
Evaluation/Red Flags
Inves9ga9ng	
  Physicians	
  
Dr.	
  	
  Bamdad,	
  Los	
  
Angeles	
  	
  
Fugitive Pill Mill Doctor (Dr. Robert Ignasiak) Who Faked Suicide Found
and Arrested in South Florida
189	
  
Perfunctory	
  ini.al	
  physical	
  exam…return	
  visits	
  no	
  exam	
  
Physical	
  exam	
  included	
  needle	
  mark	
  checks…some	
  were	
  simulated	
  
Pa.ent	
  received	
  quan.ty	
  of	
  drugs	
  requested…were	
  charged	
  based	
  
on	
  quan.ty	
  
Unsupervised	
  urinalysis	
  –	
  results	
  did	
  not	
  maGer	
  
Accurate	
  records	
  not	
  kept	
  –	
  quan.ty	
  dispensed	
  not	
  recorded	
  
Prac..oner	
  not	
  authorized	
  to	
  conduct	
  methadone	
  maintenance;	
  
Pa.ent	
  directed	
  prescribing;	
  	
   U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Rosen	
  was	
  a	
  68	
  yo	
  physician	
  who	
  had	
  a	
  prac.ce	
  that	
  was	
  focused	
  on	
  obesity.	
  He	
  
dispensed	
  large	
  quan..es	
  of	
  s.mulants	
  to	
  undercover	
  officers	
  	
  outside	
  the	
  
scope	
  and	
  not	
  for	
  a	
  legi.mate	
  purpose.	
  	
  	
  
The	
  5th	
  circuit	
  had	
  to	
  address	
  whether	
  the	
  medica.on	
  was	
  dispensed	
  “for	
  a	
  
legi.mate	
  medical	
  purpose	
  and	
  in	
  the	
  course	
  of	
  the	
  doctors	
  professional	
  
prac.ce.”	
  	
  In	
  its	
  analysis,	
  the	
  court	
  stated,	
  “We	
  are	
  however,	
  able	
  to	
  glean	
  
from	
  reported	
  cases,	
  certain	
  recurring	
  concomitance	
  of	
  condemned	
  
behavior,	
  examples	
  of	
  which	
  include	
  the	
  following:	
  	
  
An	
  inordinately	
  large	
  quan.ty	
  of	
  controlled	
  substances	
  prescribed	
  
Large	
  numbers	
  of	
  prescrip.on	
  were	
  issued	
  
No	
  physical	
  exam	
  given	
  
The	
  physician	
  warned	
  the	
  pa.ent	
  to	
  fill	
  prescrip.ons	
  at	
  different	
  	
  drug	
  stores	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Customers	
  coming	
  into	
  the	
  pharmacy	
  in	
  groups,	
  each	
  with	
  the	
  same	
  
prescrip.ons	
  issued	
  by	
  the	
  same	
  physician;	
  and	
  
Customers	
  with	
  prescrip.ons	
  for	
  controlled	
  substances	
  wriGen	
  by	
  physicians	
  not	
  
associated	
  with	
  pain	
  management	
  (i.e.,	
  pediatricians,	
  gynecologists,	
  
ophthalmologists,	
  etc.).	
  
Overwhelming	
  propor.on	
  of	
  prescrip.ons	
  filled	
  by	
  pharmacy	
  are	
  controlled	
  
substances	
  
Pharmacist	
  did	
  not	
  reach	
  out	
  to	
  other	
  pharmacists	
  to	
  determine	
  why	
  they	
  were	
  
not	
  filling	
  a	
  par.cular	
  doctors	
  prescrip.on	
  
Verifica.on	
  of	
  legi.macy	
  not	
  sa.sfied	
  by	
  a	
  call	
  to	
  the	
  doctors	
  office	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
The	
  physician	
  issued	
  prescrip.ons	
  to	
  a	
  pa.ent	
  known	
  to	
  be	
  delivering	
  the	
  drugs	
  to	
  
others	
  
The	
  physician	
  prescribed	
  controlled	
  drugs	
  at	
  intervals	
  inconsistent	
  with	
  legi.mate	
  
medical	
  treatment	
  
The	
  physician	
  involved	
  used	
  street	
  slang	
  rather	
  than	
  medical	
  terminology	
  for	
  the	
  drugs	
  
prescribed	
  
There	
  was	
  no	
  logical	
  rela.onship	
  between	
  the	
  drug	
  prescribed	
  and	
  treatment	
  of	
  the	
  
condi.on	
  allegedly	
  exis.ng	
  
The	
  physician	
  wrote	
  more	
  than	
  one	
  prescrip.on	
  on	
  occasions	
  in	
  order	
  to	
  spread	
  them	
  
out	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Pa.ents	
  receiving	
  the	
  same	
  combina.on	
  of	
  prescrip.ons;	
  cocktail	
  
Pa.ents	
  receiving	
  the	
  same	
  strength	
  of	
  controlled	
  substances;	
  no	
  individualized	
  
dosing:	
  mul.ple	
  prescrip.ons	
  for	
  the	
  strongest	
  dose	
  
Majority	
  of	
  pa.ents	
  paying	
  cash	
  for	
  their	
  prescrip.ons	
  
Pa.ent	
  directed	
  prescribing;	
  pa.ent	
  asks	
  for	
  drugs	
  in	
  street	
  slang	
  
Early	
  refills	
  
No	
  specialized	
  training	
  in	
  pain	
  management;	
  
Individuals	
  driving	
  long	
  distances	
  to	
  visit	
  physicians	
  and/or	
  to	
  fill	
  prescrip.ons	
  
No	
  records/pa.ent	
  contracts/	
  urinalysis	
  	
  
U.S.	
  Drug	
  Enforcement	
  Administra.on	
  
	
  Office	
  of	
  Diversion	
  Control	
  	
  	
  	
  
Initial verification/corroboration
–  Prescription Monitoring Programs-30 day look
–  Look for legitimate explanations of activity
–  Physical surveillance-Video
•  Patient traffic inside/outside clinic
•  Staff removing records/bags from office
•  MD/staff visiting banks
–  Database checks; prior/related investigations
–  Crosscheck with other agencies for related information
•  Professional state licensing boards-Discipline/on-going
investigations
U.S. Drug Enforcement Administration / Operations Division / Office of Diversion Control
Initial Evaluation
Inves9ga9ng	
  Physicians	
  
Inves9ga9ng	
  Physicians	
  	
  
Considerations
–  DON’T TRICK THE DOCTOR
–  Intent: evidence of “outside the scope”
–  Video/Audio recording crucial
–  Pain mention- not always a show stopper
–  MRI/Medical records- creating/patterns of use
–  Frequency of visits-multiple undercovers
–  Street slang/prices/conversation
–  Meet other patients in clinic
–  Medication prescribed for others not present
–  ASK: specific drugs/increase doses/multiple scripts
U.S. Drug Enforcement Administration / Operations Division / Office of Diversion Control
Undercover Process
Inves9ga9ng	
  Physicians	
  
Grand Jury Subpoenas
–  Banks- Laundering and asset identification
Expert Review
–  Establish Probable Cause for Search warrant/Administrative
action
–  PMP records
–  Reports: Undercover, Interviews of patients/employees
–  UC video/audio
–  Opinion: “Extreme departure” from standards
–  Sources: Professional boards/associations, teaching universities.
U.S. Drug Enforcement Administration / Operations Division / Office of Diversion Control
Investigative Process
Inves9ga9ng	
  Physicians	
  
Timing of search and arrests-considerations
–  Public safety
–  Rush to Indictment following arrest-be prepared
–  Loss of assets
–  High profile defendant-Press/political interests
–  Immediate suspension of DEA registration/state licensing action
Processing medical records
–  Know what you’re looking for
Expert Review of seized medical records
Patient and employee interviews
U.S. Drug Enforcement Administration / Operations Division / Office of Diversion Control
Search Warrants
Inves9ga9ng	
  Physicians	
  
Search warrants/affidavits
–  Get a go-by
–  Include: type of drugs, case law/statute of legitimate prescribing,
medical standards, how target violated standard, expert opinion,
specific records to seize, how to conduct search
–  Special masters not usually required in fed cases
–  Plan how to process and store records
–  Request computer forensic/doc exploitation teams
–  Electronic scanning/prosecution preference
U.S. Drug Enforcement Administration / Operations Division / Office of Diversion Control
Search Warrant Mechanics
Inves9ga9ng	
  Physicians
Appropriate Jurisdiction:	
  Federal/State (Attorney General)/District Attorney’s
Office
–  Offenses/charging/burdens/sentences all vary
Death enhancements
–  Medical examiner investigation
–  Cause of death/documentation
–  Multiple Expert opinions
Other enhancements - Distances/under age 21
Charging: UC counts/Relative conduct at sentencing
–  Medical fraud considerations
Asset Forfeiture - Criminal/civil/administrative
U.S. Drug Enforcement Administration / Operations Division / Office of Diversion Control
Prosecution	
  
Inves9ga9ng	
  Pharmacies	
  
•  Corresponding Responsibility – Unlawful Distribution
Title 21 USC 841 (a)(1)/846
•  Evidence exists that pharmacist/owner delivered drugs to (an)
individual (s) pursuant to (an) unlawful order(s) (prescription). A
“rogue” physician is typically involved.
•  Pharmacist knew or should have known that the prescription was illegal
(issued outside the course of a professional practice.)
Examples: Prescription was issued in the course of an UC operation in
exchange for cash; rx has obvious inadequacies, excessive dosages or
quantities, refills at an uncommonly high rate or indications of customer
misuse of the drug.
•  Use of Expert Witness – Pharmacists or Doctors are usually called
upon to examine prescriptions and pharmacy records to aid in
determining if the pharmacist exercised corresponding responsibility.
201	
  U.S. Drug Enforcement Administration / Operations Division / Office of Diversion Control
Legal Basis 	
  
Inves9ga9ng	
  Pharmacies	
  
•  Unlawful Distribution –Unlawful Distribution
Title 21 USC 841 (a)(1)/846
•  Evidence exists that pharmacist delivered a drug without a
lawful order (issued outside the course of a professional
practice).
•  Atypical to this case is the lack of physician involvement.
For example, UC operation details the pharmacist delivering
drugs to CS/UC in exchange for cash, and solicits CS/UC
for fraudulent rxs to cover up the diversion of drugs from
the pharmacy. (See Tampa case S/S Pharmacy, Federal
register notice dated 9/19/2013).
202	
  
Legal Basis
U.S. Drug Enforcement Administration / Operations Division / Office of Diversion Control
Inves9ga9ng	
  Pharmacies	
  
• Health Care Fraud –
•  31 U.S.C. 3729(a)(1)(A)(B): When a person knowingly makes a
false claim to receive payment from the government.
•  There must be evidence that the pharmacist filled a prescription
and billed medical insurance providers knowing the prescriptions
were not written for a legitimate medical purpose.
203	
  
Legal Basis
U.S. Drug Enforcement Administration / Operations Division / Office of Diversion Control
Inves9ga9ng	
  Pharmacies	
  
•  Chain Pharmacies-
•  Pharmacy which has national exposure: CVS; Rite Aid;
Walgreens, etc.
•  Typically targeted for civil prosecution (fines).
•  Must be coordinated with DEA HQS ODG prior field contact
with US Attorney.
•  Targeted pharmacy has numerous CSA violations (21 CFR 1300
to end) which led to facilitation of drug diversion.
204	
  
Legal Basis
U.S. Drug Enforcement Administration / Operations Division / Office of Diversion Control
Inves9ga9ng	
  Pharmacies	
  
• Sources of Information - Supplier/Distributor, Suspicious Order
Reports, Pharmacy Boards, Medical Examiners, Police Departments,
Tips from citizens, ARCOS, PDMP
• Spin-off cases – Medical Doctor, distributor investigations
• Informants - Included in routine narcotics debriefings. Cooperating
defendants/individuals.
• Government Agencies - Joint investigations with agencies such as FBI,
HHS, FDA, Homeland Security, Medical/Pharmacy Boards, etc.
• Drug Overdose Investigation - Check of Police Report of OD
deaths in area to compare to pharmacy prescription history.
What Triggers a Pharmacy Investigation
205	
  U.S. Drug Enforcement Administration / Operations Division / Office of Diversion Control
Inves9ga9ng	
  Pharmacies	
  
• Profiles - Check ARCOS, PDMP, NADDIS, NCIC, Pharmacy Board,
ChoicePoint, CLEAR, Police Department activity reports.
• Industry reports - DEA-106s, DEA-41s, Check distributor customer
report.
• Surveillance - Observation of pharmacy activity, focus on video
recordings of suspicious individuals, vehicles (out of state plates),
parking lot hand exchanges, volume of customers in parking lot
waiting to enter facility.
• Customer base – Review PMP data, identify primary source physicians and
patient profiles (age, types of drugs, distance from residence, etc)
206	
  
Conduct Background Investigation
U.S. Drug Enforcement Administration / Operations Division / Office of Diversion Control
Ringleader Robin
Steinke	
  
Pharmacist Jeff
Clawson	
  
CVS Pharmacy, Inc. Agrees to $11 Million Settlement
for Violations of the Controlled Substances Act
Large National Chain Pharmacy First Ever
DEA Registration Revocation
TDS Dismantles Oxycodone Trafficking Group and Arrests Pharmacist
PlaNe	
  Valley	
  Pharmacy	
  in	
  Brighton,	
  Colorado	
  
Sanford,	
  FL,	
  CVS	
  	
  
Inves9ga9ng	
  Pharmacies	
  
• Vehicle Stops - Stops of multiple customers may reveal drug prescription
information, doctor information, drug type, drug quantities, patient
information, develop confidential informants. Criminal checks based on
vehicle registrations. Travel from afar? Follow to storage sites.
Organized vehicle stops with Police.
• Undercover Operations - Undercover buys may reveal pharmacy illegal
procedures, CSA violations, pharmacy/tech/owner conspiratorial
members. Consensual phone calls by informant(s) to pharmacist.
• Trash searches - May produce evidence for search warrants. May also
identify information regarding additional warehouses, banking information,
additional addresses, discarded scripts, etc.
209	
  
Evidence Gathering Techniques
U.S. Drug Enforcement Administration / Operations Division / Office of Diversion Control
Inves9ga9ng	
  Pharmacies	
  
• Video - Review any available video from inside pharmacy, consider
obtaining court order to bug pharmacy.
• Financial Check - Conduct financial investigation on pharmacist to
uncover unusual large cash deposits, bank accounts, associated assets.
•  Purpose of investigative methods will aid in establishing probable
cause for a search warrant and identify conspirators.
210	
  
Evidence Gathering Techniques (cont’d.)
U.S. Drug Enforcement Administration / Operations Division / Office of Diversion Control
Inves9ga9ng	
  Pharmacies	
  
• Criminal Actions - Determine if evidence exists to prove the following
statutes:
•  21 U.S.C. 841(a)(1) – Illegal Distribution
•  21 U.S. C. 843(a)(3) – To acquire or obtain possession of a controlled
substance by misrepresentation, fraud, forgery, deception or subterfuge
• Civil Actions - Determine if there is a preponderance of evidence indicating
a violation of the following statutes:
•  21 U.S.C. 842(a)(1) – Dispensing outside the course of normal practice
•  21 U.S. C. 842(a)(5) – Violation of CSA, recordkeeping and reporting
requirements (Title 21 CFR 1300 to end).	
  
211	
  
Review Case to determine applicable
Administration, Civil or Criminal Actions
U.S. Drug Enforcement Administration / Operations Division / Office of Diversion Control
Inves9ga9ng	
  Pharmacies	
  
• Administrative - Immediate Suspension Order/Order to Show
Cause- Determine if grounds exists under the following factors:
• (1) The recommendation of the appropriate State licensing board or professional
disciplinary authority: license revocation/suspension; admin findings relating to drug
violations, etc.
• (2) The applicant's experience in dispensing, or conducting research with respect to
controlled substances: unlawful drug distribution; health care fraud conviction, etc.
• (3) The applicant's conviction record under Federal or State laws relating to the
manufacture, distribution, or dispensing of controlled substances.
• (4) Compliance with applicable State, Federal, or local laws relating to controlled
substances.
• (5) Such other conduct which may threaten the public health and safety.
• *Need one or more factor to recommend OTSC/ISO action.
212	
  
Review Case to determine applicable
Administration, Civil or Criminal Actions (cont’d.)
U.S. Drug Enforcement Administration / Operations Division / Office of Diversion Control
• Other Administrative Actions - Determine if violations of Title 21 CFR
1300 to end:
•  Memorandum of Agreement (MOA) – Specifies terms of registrant’s
future compliance. Violation of terms is grounds for an OTSC.
•  Letter of Admonition (LOA) – Notifies the registrant in writing of CSA
violations and requires that he/she remedies same.
•  Investigative Warning – Investigator advises registrant of CSA
violations and requires that he/she remedies same.
Note: Controlled Substance Act of 1970 outlines regulations for registrants
regarding the proper handling of controlled substances. Violations of this act
are usually remedied through civil/administrative actions
Inves9ga9ng	
  Pharmacies	
  
213	
  
Review Case to determine applicable Administration,
Civil or Criminal Actions (cont’d.)
U.S. Drug Enforcement Administration / Operations Division / Office of Diversion Control
Inves9ga9ng	
  Pharmacies	
  
• Search Warrant - Handled the same as normal search warrants but are
usually executed without force.
• Administrative Inspection Warrant (AIW) -
•  Issued by a Federal Magistrate.
•  Limited to records required to be kept under 21 CFR 1300 to end.
Examples: Order Forms, Invoices, prescriptions, inventories, etc.
•  Has to be conducted during business hours in a professional manner.
•  Notice of Inspection (DEA Form – 82) –
•  Issued by assigned Agent/Investigator/TFO (deputized)
•  Limited to required records relating to 21 CFR 1300 to end.
•  Only copies can be taken without consent.
214	
  
Methods of obtaining pharmacy documentary evidence
U.S. Drug Enforcement Administration / Operations Division / Office of Diversion Control
Inves9ga9ng	
  Pharmacies	
  
• Arrests/Indictments
• Seized Assets
• Civil Fines
•  Civil fines are payable to the Department of Justice and are not subject
to asset sharing
• Registration Revocation/Suspension Orders
•  Issued by Office of Chief Counsel (CCD)
• Other Administrative Actions
• Sentencing
•  Sentencing is enhanced if wrongful death is proven and Schedule II
narcotics are involved and quantified.
215	
  
Investigative Outcomes
U.S. Drug Enforcement Administration / Operations Division / Office of Diversion Control
Len 1 rannazzisi
Len 1 rannazzisi

Contenu connexe

Tendances

The Opioid Epidemic: An Important Auditor Update
The Opioid Epidemic: An Important Auditor UpdateThe Opioid Epidemic: An Important Auditor Update
The Opioid Epidemic: An Important Auditor UpdatePYA, P.C.
 
Miami dade-den-report-2009-2010
Miami dade-den-report-2009-2010Miami dade-den-report-2009-2010
Miami dade-den-report-2009-2010satoriwatersfl
 
Tuesday astho
Tuesday asthoTuesday astho
Tuesday asthoOPUNITE
 
Tpp 1 walls abou_nader
Tpp 1 walls abou_naderTpp 1 walls abou_nader
Tpp 1 walls abou_naderOPUNITE
 
Rx15 vi sion_tues_800_ameritox
Rx15 vi sion_tues_800_ameritoxRx15 vi sion_tues_800_ameritox
Rx15 vi sion_tues_800_ameritoxOPUNITE
 
Rx15 vision tues_200_pew_1_reilly_2wendt_3kachur_4nader
Rx15 vision tues_200_pew_1_reilly_2wendt_3kachur_4naderRx15 vision tues_200_pew_1_reilly_2wendt_3kachur_4nader
Rx15 vision tues_200_pew_1_reilly_2wendt_3kachur_4naderOPUNITE
 
Rx16 federal tues_330_1_spitznas_2baldwin_3welch
Rx16 federal tues_330_1_spitznas_2baldwin_3welchRx16 federal tues_330_1_spitznas_2baldwin_3welch
Rx16 federal tues_330_1_spitznas_2baldwin_3welchOPUNITE
 
Effective Strategies For Intervening With Drug Abusing Offenders
Effective Strategies For Intervening With Drug Abusing OffendersEffective Strategies For Intervening With Drug Abusing Offenders
Effective Strategies For Intervening With Drug Abusing Offenderslakatos
 
Gao recommendations to CMS
Gao recommendations to CMSGao recommendations to CMS
Gao recommendations to CMSPaul Coelho, MD
 
Rx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelliRx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelliOPUNITE
 
Dr. Tom Frieden keynote
Dr. Tom Frieden keynoteDr. Tom Frieden keynote
Dr. Tom Frieden keynoteOPUNITE
 
Hawaii Governor David Ige - Statewide Initiative on Opioids and Substance Abuse
Hawaii Governor David Ige - Statewide Initiative on Opioids and Substance AbuseHawaii Governor David Ige - Statewide Initiative on Opioids and Substance Abuse
Hawaii Governor David Ige - Statewide Initiative on Opioids and Substance AbuseClifton M. Hasegawa & Associates, LLC
 
Opioid related hospitalizations by state
Opioid related hospitalizations by stateOpioid related hospitalizations by state
Opioid related hospitalizations by statePaul Coelho, MD
 
Drugged drivingnadcp5.12
Drugged drivingnadcp5.12Drugged drivingnadcp5.12
Drugged drivingnadcp5.12CADCP
 
Web only rx16 len wed_1230_1_daugherty_2baier-haas
Web only rx16 len wed_1230_1_daugherty_2baier-haasWeb only rx16 len wed_1230_1_daugherty_2baier-haas
Web only rx16 len wed_1230_1_daugherty_2baier-haasOPUNITE
 
Kana Enomoto keynote
Kana Enomoto keynoteKana Enomoto keynote
Kana Enomoto keynoteOPUNITE
 
Rx16 vs claad_tues_800_group
Rx16 vs claad_tues_800_groupRx16 vs claad_tues_800_group
Rx16 vs claad_tues_800_groupOPUNITE
 

Tendances (20)

The Opioid Epidemic: An Important Auditor Update
The Opioid Epidemic: An Important Auditor UpdateThe Opioid Epidemic: An Important Auditor Update
The Opioid Epidemic: An Important Auditor Update
 
Miami dade-den-report-2009-2010
Miami dade-den-report-2009-2010Miami dade-den-report-2009-2010
Miami dade-den-report-2009-2010
 
Tuesday astho
Tuesday asthoTuesday astho
Tuesday astho
 
Tpp 1 walls abou_nader
Tpp 1 walls abou_naderTpp 1 walls abou_nader
Tpp 1 walls abou_nader
 
Rx15 vi sion_tues_800_ameritox
Rx15 vi sion_tues_800_ameritoxRx15 vi sion_tues_800_ameritox
Rx15 vi sion_tues_800_ameritox
 
Rx15 vision tues_200_pew_1_reilly_2wendt_3kachur_4nader
Rx15 vision tues_200_pew_1_reilly_2wendt_3kachur_4naderRx15 vision tues_200_pew_1_reilly_2wendt_3kachur_4nader
Rx15 vision tues_200_pew_1_reilly_2wendt_3kachur_4nader
 
14drugpr
14drugpr14drugpr
14drugpr
 
Rx16 federal tues_330_1_spitznas_2baldwin_3welch
Rx16 federal tues_330_1_spitznas_2baldwin_3welchRx16 federal tues_330_1_spitznas_2baldwin_3welch
Rx16 federal tues_330_1_spitznas_2baldwin_3welch
 
Effective Strategies For Intervening With Drug Abusing Offenders
Effective Strategies For Intervening With Drug Abusing OffendersEffective Strategies For Intervening With Drug Abusing Offenders
Effective Strategies For Intervening With Drug Abusing Offenders
 
Gao recommendations to CMS
Gao recommendations to CMSGao recommendations to CMS
Gao recommendations to CMS
 
Rx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelliRx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelli
 
Dr. Tom Frieden keynote
Dr. Tom Frieden keynoteDr. Tom Frieden keynote
Dr. Tom Frieden keynote
 
Hawaii Governor David Ige - Statewide Initiative on Opioids and Substance Abuse
Hawaii Governor David Ige - Statewide Initiative on Opioids and Substance AbuseHawaii Governor David Ige - Statewide Initiative on Opioids and Substance Abuse
Hawaii Governor David Ige - Statewide Initiative on Opioids and Substance Abuse
 
Opioid related hospitalizations by state
Opioid related hospitalizations by stateOpioid related hospitalizations by state
Opioid related hospitalizations by state
 
Drugged drivingnadcp5.12
Drugged drivingnadcp5.12Drugged drivingnadcp5.12
Drugged drivingnadcp5.12
 
Web only rx16 len wed_1230_1_daugherty_2baier-haas
Web only rx16 len wed_1230_1_daugherty_2baier-haasWeb only rx16 len wed_1230_1_daugherty_2baier-haas
Web only rx16 len wed_1230_1_daugherty_2baier-haas
 
Prescription Drug Abuse in America
Prescription Drug Abuse in AmericaPrescription Drug Abuse in America
Prescription Drug Abuse in America
 
Kana Enomoto keynote
Kana Enomoto keynoteKana Enomoto keynote
Kana Enomoto keynote
 
Survey 2009drugod
Survey 2009drugodSurvey 2009drugod
Survey 2009drugod
 
Rx16 vs claad_tues_800_group
Rx16 vs claad_tues_800_groupRx16 vs claad_tues_800_group
Rx16 vs claad_tues_800_group
 

Similaire à Len 1 rannazzisi

Green pt1 state-pmp
Green pt1 state-pmpGreen pt1 state-pmp
Green pt1 state-pmpWelcome40
 
Rx15 tt tues_1230_1_carnevale_2green_3paone-tuazon
Rx15 tt tues_1230_1_carnevale_2green_3paone-tuazonRx15 tt tues_1230_1_carnevale_2green_3paone-tuazon
Rx15 tt tues_1230_1_carnevale_2green_3paone-tuazonOPUNITE
 
Overview of the Public Health Burden of Prescription Drug and Heroin Overdos...
Overview of the Public Health  Burden of Prescription Drug and Heroin Overdos...Overview of the Public Health  Burden of Prescription Drug and Heroin Overdos...
Overview of the Public Health Burden of Prescription Drug and Heroin Overdos...University of Michigan Injury Center
 
Wed vs ondcp labelle
Wed vs ondcp labelleWed vs ondcp labelle
Wed vs ondcp labelleOPUNITE
 
Treatment Programs HARPS Program (Helping At-Risk Pregnant Women Succeed) - C...
Treatment Programs HARPS Program (Helping At-Risk Pregnant Women Succeed) - C...Treatment Programs HARPS Program (Helping At-Risk Pregnant Women Succeed) - C...
Treatment Programs HARPS Program (Helping At-Risk Pregnant Women Succeed) - C...ErikaAGoyer
 
WV Newsletter March 2015
WV Newsletter March 2015WV Newsletter March 2015
WV Newsletter March 2015Steve Espy
 
Rx16 pharma tues_1230_1_ashley
Rx16 pharma tues_1230_1_ashleyRx16 pharma tues_1230_1_ashley
Rx16 pharma tues_1230_1_ashleyOPUNITE
 
Hendricks, the use and abuse of prescription drug nfjca v3 n1 2014
Hendricks, the use and abuse of prescription drug nfjca v3 n1 2014Hendricks, the use and abuse of prescription drug nfjca v3 n1 2014
Hendricks, the use and abuse of prescription drug nfjca v3 n1 2014William Kritsonis
 
Public Acceptance for Drug Treatment in Lieu of Incarceration fo.docx
Public Acceptance for Drug Treatment in Lieu of Incarceration fo.docxPublic Acceptance for Drug Treatment in Lieu of Incarceration fo.docx
Public Acceptance for Drug Treatment in Lieu of Incarceration fo.docxwoodruffeloisa
 
The economic burden of prescription opioid overdose... 2013.
The economic burden of prescription opioid overdose... 2013.The economic burden of prescription opioid overdose... 2013.
The economic burden of prescription opioid overdose... 2013.Paul Coelho, MD
 
Dr Sabet Power Point Final Sept 23, 2013
Dr Sabet Power Point Final Sept 23, 2013Dr Sabet Power Point Final Sept 23, 2013
Dr Sabet Power Point Final Sept 23, 2013Heidi Denton
 
Global Medical Cures™ | Get Smart about Drugs- How Teens Abuse Medicine
Global Medical Cures™ | Get Smart about Drugs- How Teens Abuse Medicine Global Medical Cures™ | Get Smart about Drugs- How Teens Abuse Medicine
Global Medical Cures™ | Get Smart about Drugs- How Teens Abuse Medicine Global Medical Cures™
 
Prescription Drug Abuse in the USA
Prescription Drug Abuse in the USAPrescription Drug Abuse in the USA
Prescription Drug Abuse in the USAJack Tonkin
 
Running head DRUG TRAFFICKING 1DRUG TRAFFICKING 2.docx
Running head DRUG TRAFFICKING 1DRUG TRAFFICKING 2.docxRunning head DRUG TRAFFICKING 1DRUG TRAFFICKING 2.docx
Running head DRUG TRAFFICKING 1DRUG TRAFFICKING 2.docxtodd271
 
Critical Analysis of Substance Abuse
Critical Analysis of Substance AbuseCritical Analysis of Substance Abuse
Critical Analysis of Substance AbuseAlexandraPerkins5
 
State profile -_new_york_0
State profile -_new_york_0State profile -_new_york_0
State profile -_new_york_0satoriwatersfl
 
Undocumented Immigration, Drug Problems, andDriving Under th.docx
Undocumented Immigration, Drug Problems, andDriving Under th.docxUndocumented Immigration, Drug Problems, andDriving Under th.docx
Undocumented Immigration, Drug Problems, andDriving Under th.docxouldparis
 
Emerging public health issue: Prescription Overdose
Emerging public health issue: Prescription OverdoseEmerging public health issue: Prescription Overdose
Emerging public health issue: Prescription OverdoseTosin Ola-Weissmann
 

Similaire à Len 1 rannazzisi (20)

Green pt1 state-pmp
Green pt1 state-pmpGreen pt1 state-pmp
Green pt1 state-pmp
 
Rx15 tt tues_1230_1_carnevale_2green_3paone-tuazon
Rx15 tt tues_1230_1_carnevale_2green_3paone-tuazonRx15 tt tues_1230_1_carnevale_2green_3paone-tuazon
Rx15 tt tues_1230_1_carnevale_2green_3paone-tuazon
 
Overview of the Public Health Burden of Prescription Drug and Heroin Overdos...
Overview of the Public Health  Burden of Prescription Drug and Heroin Overdos...Overview of the Public Health  Burden of Prescription Drug and Heroin Overdos...
Overview of the Public Health Burden of Prescription Drug and Heroin Overdos...
 
Wed vs ondcp labelle
Wed vs ondcp labelleWed vs ondcp labelle
Wed vs ondcp labelle
 
Treatment Programs HARPS Program (Helping At-Risk Pregnant Women Succeed) - C...
Treatment Programs HARPS Program (Helping At-Risk Pregnant Women Succeed) - C...Treatment Programs HARPS Program (Helping At-Risk Pregnant Women Succeed) - C...
Treatment Programs HARPS Program (Helping At-Risk Pregnant Women Succeed) - C...
 
WV Newsletter March 2015
WV Newsletter March 2015WV Newsletter March 2015
WV Newsletter March 2015
 
Rx16 pharma tues_1230_1_ashley
Rx16 pharma tues_1230_1_ashleyRx16 pharma tues_1230_1_ashley
Rx16 pharma tues_1230_1_ashley
 
Hendricks, the use and abuse of prescription drug nfjca v3 n1 2014
Hendricks, the use and abuse of prescription drug nfjca v3 n1 2014Hendricks, the use and abuse of prescription drug nfjca v3 n1 2014
Hendricks, the use and abuse of prescription drug nfjca v3 n1 2014
 
Newyorkcity2014
Newyorkcity2014Newyorkcity2014
Newyorkcity2014
 
Public Acceptance for Drug Treatment in Lieu of Incarceration fo.docx
Public Acceptance for Drug Treatment in Lieu of Incarceration fo.docxPublic Acceptance for Drug Treatment in Lieu of Incarceration fo.docx
Public Acceptance for Drug Treatment in Lieu of Incarceration fo.docx
 
The economic burden of prescription opioid overdose... 2013.
The economic burden of prescription opioid overdose... 2013.The economic burden of prescription opioid overdose... 2013.
The economic burden of prescription opioid overdose... 2013.
 
Dr Sabet Power Point Final Sept 23, 2013
Dr Sabet Power Point Final Sept 23, 2013Dr Sabet Power Point Final Sept 23, 2013
Dr Sabet Power Point Final Sept 23, 2013
 
Global Medical Cures™ | Get Smart about Drugs- How Teens Abuse Medicine
Global Medical Cures™ | Get Smart about Drugs- How Teens Abuse Medicine Global Medical Cures™ | Get Smart about Drugs- How Teens Abuse Medicine
Global Medical Cures™ | Get Smart about Drugs- How Teens Abuse Medicine
 
Prescription Drug Abuse in the USA
Prescription Drug Abuse in the USAPrescription Drug Abuse in the USA
Prescription Drug Abuse in the USA
 
Running head DRUG TRAFFICKING 1DRUG TRAFFICKING 2.docx
Running head DRUG TRAFFICKING 1DRUG TRAFFICKING 2.docxRunning head DRUG TRAFFICKING 1DRUG TRAFFICKING 2.docx
Running head DRUG TRAFFICKING 1DRUG TRAFFICKING 2.docx
 
aidslinedec13
aidslinedec13aidslinedec13
aidslinedec13
 
Critical Analysis of Substance Abuse
Critical Analysis of Substance AbuseCritical Analysis of Substance Abuse
Critical Analysis of Substance Abuse
 
State profile -_new_york_0
State profile -_new_york_0State profile -_new_york_0
State profile -_new_york_0
 
Undocumented Immigration, Drug Problems, andDriving Under th.docx
Undocumented Immigration, Drug Problems, andDriving Under th.docxUndocumented Immigration, Drug Problems, andDriving Under th.docx
Undocumented Immigration, Drug Problems, andDriving Under th.docx
 
Emerging public health issue: Prescription Overdose
Emerging public health issue: Prescription OverdoseEmerging public health issue: Prescription Overdose
Emerging public health issue: Prescription Overdose
 

Plus de OPUNITE

Dr. Francis Collins keynote
Dr. Francis Collins keynoteDr. Francis Collins keynote
Dr. Francis Collins keynoteOPUNITE
 
Rx16 claad tue-vision_final
Rx16 claad tue-vision_finalRx16 claad tue-vision_final
Rx16 claad tue-vision_finalOPUNITE
 
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerRx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerOPUNITE
 
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingWeb rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingOPUNITE
 
Rx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copyRx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copyOPUNITE
 
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copyWeb rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copyOPUNITE
 
Rx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenRx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenOPUNITE
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingOPUNITE
 
Rx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategiesRx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategiesOPUNITE
 
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessWeb only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessOPUNITE
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingOPUNITE
 
Rx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2priceRx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2priceOPUNITE
 
Rx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earleRx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earleOPUNITE
 
Rx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblattRx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblattOPUNITE
 
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanWeb only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanOPUNITE
 
Rx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_millerRx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_millerOPUNITE
 
Rx16 tpp wed_200_group
Rx16 tpp wed_200_groupRx16 tpp wed_200_group
Rx16 tpp wed_200_groupOPUNITE
 
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnold
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnoldRx16 prevent wed_200_1_cairnes-wertnepy_2arnold
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnoldOPUNITE
 
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachioWeb only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachioOPUNITE
 
Rx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldberger
Rx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldbergerRx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldberger
Rx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldbergerOPUNITE
 

Plus de OPUNITE (20)

Dr. Francis Collins keynote
Dr. Francis Collins keynoteDr. Francis Collins keynote
Dr. Francis Collins keynote
 
Rx16 claad tue-vision_final
Rx16 claad tue-vision_finalRx16 claad tue-vision_final
Rx16 claad tue-vision_final
 
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerRx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
 
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingWeb rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
 
Rx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copyRx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copy
 
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copyWeb rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
 
Rx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenRx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsen
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
 
Rx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategiesRx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategies
 
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessWeb only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
 
Rx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2priceRx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2price
 
Rx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earleRx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earle
 
Rx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblattRx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblatt
 
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanWeb only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
 
Rx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_millerRx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_miller
 
Rx16 tpp wed_200_group
Rx16 tpp wed_200_groupRx16 tpp wed_200_group
Rx16 tpp wed_200_group
 
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnold
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnoldRx16 prevent wed_200_1_cairnes-wertnepy_2arnold
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnold
 
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachioWeb only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
Web only rx16 pharma wed_200_1_hagemeier_2fleming_3vernachio
 
Rx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldberger
Rx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldbergerRx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldberger
Rx16 pdmp wed_200_1_frick_2zadrazil_3delcher-goldberger
 

Dernier

Call 8250092165 Patna Call Girls ₹4.5k Cash Payment With Room Delivery
Call 8250092165 Patna Call Girls ₹4.5k Cash Payment With Room DeliveryCall 8250092165 Patna Call Girls ₹4.5k Cash Payment With Room Delivery
Call 8250092165 Patna Call Girls ₹4.5k Cash Payment With Room DeliveryJyoti singh
 
Independent Bangalore Call Girls (Adult Only) 💯Call Us 🔝 7304373326 🔝 💃 Escor...
Independent Bangalore Call Girls (Adult Only) 💯Call Us 🔝 7304373326 🔝 💃 Escor...Independent Bangalore Call Girls (Adult Only) 💯Call Us 🔝 7304373326 🔝 💃 Escor...
Independent Bangalore Call Girls (Adult Only) 💯Call Us 🔝 7304373326 🔝 💃 Escor...Sheetaleventcompany
 
Dehradun Call Girls Service {8854095900} ❤️VVIP ROCKY Call Girl in Dehradun U...
Dehradun Call Girls Service {8854095900} ❤️VVIP ROCKY Call Girl in Dehradun U...Dehradun Call Girls Service {8854095900} ❤️VVIP ROCKY Call Girl in Dehradun U...
Dehradun Call Girls Service {8854095900} ❤️VVIP ROCKY Call Girl in Dehradun U...Sheetaleventcompany
 
Goa Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Goa No💰Advanc...
Goa Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Goa No💰Advanc...Goa Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Goa No💰Advanc...
Goa Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Goa No💰Advanc...Sheetaleventcompany
 
💚Call Girls In Amritsar 💯Anvi 📲🔝8725944379🔝Amritsar Call Girl No💰Advance Cash...
💚Call Girls In Amritsar 💯Anvi 📲🔝8725944379🔝Amritsar Call Girl No💰Advance Cash...💚Call Girls In Amritsar 💯Anvi 📲🔝8725944379🔝Amritsar Call Girl No💰Advance Cash...
💚Call Girls In Amritsar 💯Anvi 📲🔝8725944379🔝Amritsar Call Girl No💰Advance Cash...Sheetaleventcompany
 
Call Girls in Lucknow Just Call 👉👉 8875999948 Top Class Call Girl Service Ava...
Call Girls in Lucknow Just Call 👉👉 8875999948 Top Class Call Girl Service Ava...Call Girls in Lucknow Just Call 👉👉 8875999948 Top Class Call Girl Service Ava...
Call Girls in Lucknow Just Call 👉👉 8875999948 Top Class Call Girl Service Ava...Janvi Singh
 
Call Girls Kathua Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Kathua Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Kathua Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Kathua Just Call 8250077686 Top Class Call Girl Service AvailableDipal Arora
 
Cardiac Output, Venous Return, and Their Regulation
Cardiac Output, Venous Return, and Their RegulationCardiac Output, Venous Return, and Their Regulation
Cardiac Output, Venous Return, and Their RegulationMedicoseAcademics
 
❤️Chandigarh Escorts Service☎️9814379184☎️ Call Girl service in Chandigarh☎️ ...
❤️Chandigarh Escorts Service☎️9814379184☎️ Call Girl service in Chandigarh☎️ ...❤️Chandigarh Escorts Service☎️9814379184☎️ Call Girl service in Chandigarh☎️ ...
❤️Chandigarh Escorts Service☎️9814379184☎️ Call Girl service in Chandigarh☎️ ...Sheetaleventcompany
 
Low Cost Call Girls Bangalore {9179660964} ❤️VVIP NISHA Call Girls in Bangalo...
Low Cost Call Girls Bangalore {9179660964} ❤️VVIP NISHA Call Girls in Bangalo...Low Cost Call Girls Bangalore {9179660964} ❤️VVIP NISHA Call Girls in Bangalo...
Low Cost Call Girls Bangalore {9179660964} ❤️VVIP NISHA Call Girls in Bangalo...Sheetaleventcompany
 
💚Chandigarh Call Girls Service 💯Piya 📲🔝8868886958🔝Call Girls In Chandigarh No...
💚Chandigarh Call Girls Service 💯Piya 📲🔝8868886958🔝Call Girls In Chandigarh No...💚Chandigarh Call Girls Service 💯Piya 📲🔝8868886958🔝Call Girls In Chandigarh No...
💚Chandigarh Call Girls Service 💯Piya 📲🔝8868886958🔝Call Girls In Chandigarh No...Sheetaleventcompany
 
Kolkata Call Girls Service ❤️🍑 9xx000xx09 👄🫦 Independent Escort Service Kolka...
Kolkata Call Girls Service ❤️🍑 9xx000xx09 👄🫦 Independent Escort Service Kolka...Kolkata Call Girls Service ❤️🍑 9xx000xx09 👄🫦 Independent Escort Service Kolka...
Kolkata Call Girls Service ❤️🍑 9xx000xx09 👄🫦 Independent Escort Service Kolka...Sheetaleventcompany
 
Exclusive Call Girls Bangalore {7304373326} ❤️VVIP POOJA Call Girls in Bangal...
Exclusive Call Girls Bangalore {7304373326} ❤️VVIP POOJA Call Girls in Bangal...Exclusive Call Girls Bangalore {7304373326} ❤️VVIP POOJA Call Girls in Bangal...
Exclusive Call Girls Bangalore {7304373326} ❤️VVIP POOJA Call Girls in Bangal...Sheetaleventcompany
 
tongue disease lecture Dr Assadawy legacy
tongue disease lecture Dr Assadawy legacytongue disease lecture Dr Assadawy legacy
tongue disease lecture Dr Assadawy legacyDrMohamed Assadawy
 
ANATOMY AND PHYSIOLOGY OF REPRODUCTIVE SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF REPRODUCTIVE SYSTEM.pptxANATOMY AND PHYSIOLOGY OF REPRODUCTIVE SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF REPRODUCTIVE SYSTEM.pptxSwetaba Besh
 
Chennai ❣️ Call Girl 6378878445 Call Girls in Chennai Escort service book now
Chennai ❣️ Call Girl 6378878445 Call Girls in Chennai Escort service book nowChennai ❣️ Call Girl 6378878445 Call Girls in Chennai Escort service book now
Chennai ❣️ Call Girl 6378878445 Call Girls in Chennai Escort service book nowtanudubay92
 
❤️Amritsar Escorts Service☎️9815674956☎️ Call Girl service in Amritsar☎️ Amri...
❤️Amritsar Escorts Service☎️9815674956☎️ Call Girl service in Amritsar☎️ Amri...❤️Amritsar Escorts Service☎️9815674956☎️ Call Girl service in Amritsar☎️ Amri...
❤️Amritsar Escorts Service☎️9815674956☎️ Call Girl service in Amritsar☎️ Amri...Sheetaleventcompany
 
ANATOMY AND PHYSIOLOGY OF RESPIRATORY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF RESPIRATORY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF RESPIRATORY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF RESPIRATORY SYSTEM.pptxSwetaba Besh
 
Call Girls Mussoorie Just Call 8854095900 Top Class Call Girl Service Available
Call Girls Mussoorie Just Call 8854095900 Top Class Call Girl Service AvailableCall Girls Mussoorie Just Call 8854095900 Top Class Call Girl Service Available
Call Girls Mussoorie Just Call 8854095900 Top Class Call Girl Service AvailableJanvi Singh
 
💚Reliable Call Girls Chandigarh 💯Niamh 📲🔝8868886958🔝Call Girl In Chandigarh N...
💚Reliable Call Girls Chandigarh 💯Niamh 📲🔝8868886958🔝Call Girl In Chandigarh N...💚Reliable Call Girls Chandigarh 💯Niamh 📲🔝8868886958🔝Call Girl In Chandigarh N...
💚Reliable Call Girls Chandigarh 💯Niamh 📲🔝8868886958🔝Call Girl In Chandigarh N...Sheetaleventcompany
 

Dernier (20)

Call 8250092165 Patna Call Girls ₹4.5k Cash Payment With Room Delivery
Call 8250092165 Patna Call Girls ₹4.5k Cash Payment With Room DeliveryCall 8250092165 Patna Call Girls ₹4.5k Cash Payment With Room Delivery
Call 8250092165 Patna Call Girls ₹4.5k Cash Payment With Room Delivery
 
Independent Bangalore Call Girls (Adult Only) 💯Call Us 🔝 7304373326 🔝 💃 Escor...
Independent Bangalore Call Girls (Adult Only) 💯Call Us 🔝 7304373326 🔝 💃 Escor...Independent Bangalore Call Girls (Adult Only) 💯Call Us 🔝 7304373326 🔝 💃 Escor...
Independent Bangalore Call Girls (Adult Only) 💯Call Us 🔝 7304373326 🔝 💃 Escor...
 
Dehradun Call Girls Service {8854095900} ❤️VVIP ROCKY Call Girl in Dehradun U...
Dehradun Call Girls Service {8854095900} ❤️VVIP ROCKY Call Girl in Dehradun U...Dehradun Call Girls Service {8854095900} ❤️VVIP ROCKY Call Girl in Dehradun U...
Dehradun Call Girls Service {8854095900} ❤️VVIP ROCKY Call Girl in Dehradun U...
 
Goa Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Goa No💰Advanc...
Goa Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Goa No💰Advanc...Goa Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Goa No💰Advanc...
Goa Call Girl Service 📞9xx000xx09📞Just Call Divya📲 Call Girl In Goa No💰Advanc...
 
💚Call Girls In Amritsar 💯Anvi 📲🔝8725944379🔝Amritsar Call Girl No💰Advance Cash...
💚Call Girls In Amritsar 💯Anvi 📲🔝8725944379🔝Amritsar Call Girl No💰Advance Cash...💚Call Girls In Amritsar 💯Anvi 📲🔝8725944379🔝Amritsar Call Girl No💰Advance Cash...
💚Call Girls In Amritsar 💯Anvi 📲🔝8725944379🔝Amritsar Call Girl No💰Advance Cash...
 
Call Girls in Lucknow Just Call 👉👉 8875999948 Top Class Call Girl Service Ava...
Call Girls in Lucknow Just Call 👉👉 8875999948 Top Class Call Girl Service Ava...Call Girls in Lucknow Just Call 👉👉 8875999948 Top Class Call Girl Service Ava...
Call Girls in Lucknow Just Call 👉👉 8875999948 Top Class Call Girl Service Ava...
 
Call Girls Kathua Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Kathua Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Kathua Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Kathua Just Call 8250077686 Top Class Call Girl Service Available
 
Cardiac Output, Venous Return, and Their Regulation
Cardiac Output, Venous Return, and Their RegulationCardiac Output, Venous Return, and Their Regulation
Cardiac Output, Venous Return, and Their Regulation
 
❤️Chandigarh Escorts Service☎️9814379184☎️ Call Girl service in Chandigarh☎️ ...
❤️Chandigarh Escorts Service☎️9814379184☎️ Call Girl service in Chandigarh☎️ ...❤️Chandigarh Escorts Service☎️9814379184☎️ Call Girl service in Chandigarh☎️ ...
❤️Chandigarh Escorts Service☎️9814379184☎️ Call Girl service in Chandigarh☎️ ...
 
Low Cost Call Girls Bangalore {9179660964} ❤️VVIP NISHA Call Girls in Bangalo...
Low Cost Call Girls Bangalore {9179660964} ❤️VVIP NISHA Call Girls in Bangalo...Low Cost Call Girls Bangalore {9179660964} ❤️VVIP NISHA Call Girls in Bangalo...
Low Cost Call Girls Bangalore {9179660964} ❤️VVIP NISHA Call Girls in Bangalo...
 
💚Chandigarh Call Girls Service 💯Piya 📲🔝8868886958🔝Call Girls In Chandigarh No...
💚Chandigarh Call Girls Service 💯Piya 📲🔝8868886958🔝Call Girls In Chandigarh No...💚Chandigarh Call Girls Service 💯Piya 📲🔝8868886958🔝Call Girls In Chandigarh No...
💚Chandigarh Call Girls Service 💯Piya 📲🔝8868886958🔝Call Girls In Chandigarh No...
 
Kolkata Call Girls Service ❤️🍑 9xx000xx09 👄🫦 Independent Escort Service Kolka...
Kolkata Call Girls Service ❤️🍑 9xx000xx09 👄🫦 Independent Escort Service Kolka...Kolkata Call Girls Service ❤️🍑 9xx000xx09 👄🫦 Independent Escort Service Kolka...
Kolkata Call Girls Service ❤️🍑 9xx000xx09 👄🫦 Independent Escort Service Kolka...
 
Exclusive Call Girls Bangalore {7304373326} ❤️VVIP POOJA Call Girls in Bangal...
Exclusive Call Girls Bangalore {7304373326} ❤️VVIP POOJA Call Girls in Bangal...Exclusive Call Girls Bangalore {7304373326} ❤️VVIP POOJA Call Girls in Bangal...
Exclusive Call Girls Bangalore {7304373326} ❤️VVIP POOJA Call Girls in Bangal...
 
tongue disease lecture Dr Assadawy legacy
tongue disease lecture Dr Assadawy legacytongue disease lecture Dr Assadawy legacy
tongue disease lecture Dr Assadawy legacy
 
ANATOMY AND PHYSIOLOGY OF REPRODUCTIVE SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF REPRODUCTIVE SYSTEM.pptxANATOMY AND PHYSIOLOGY OF REPRODUCTIVE SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF REPRODUCTIVE SYSTEM.pptx
 
Chennai ❣️ Call Girl 6378878445 Call Girls in Chennai Escort service book now
Chennai ❣️ Call Girl 6378878445 Call Girls in Chennai Escort service book nowChennai ❣️ Call Girl 6378878445 Call Girls in Chennai Escort service book now
Chennai ❣️ Call Girl 6378878445 Call Girls in Chennai Escort service book now
 
❤️Amritsar Escorts Service☎️9815674956☎️ Call Girl service in Amritsar☎️ Amri...
❤️Amritsar Escorts Service☎️9815674956☎️ Call Girl service in Amritsar☎️ Amri...❤️Amritsar Escorts Service☎️9815674956☎️ Call Girl service in Amritsar☎️ Amri...
❤️Amritsar Escorts Service☎️9815674956☎️ Call Girl service in Amritsar☎️ Amri...
 
ANATOMY AND PHYSIOLOGY OF RESPIRATORY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF RESPIRATORY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF RESPIRATORY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF RESPIRATORY SYSTEM.pptx
 
Call Girls Mussoorie Just Call 8854095900 Top Class Call Girl Service Available
Call Girls Mussoorie Just Call 8854095900 Top Class Call Girl Service AvailableCall Girls Mussoorie Just Call 8854095900 Top Class Call Girl Service Available
Call Girls Mussoorie Just Call 8854095900 Top Class Call Girl Service Available
 
💚Reliable Call Girls Chandigarh 💯Niamh 📲🔝8868886958🔝Call Girl In Chandigarh N...
💚Reliable Call Girls Chandigarh 💯Niamh 📲🔝8868886958🔝Call Girl In Chandigarh N...💚Reliable Call Girls Chandigarh 💯Niamh 📲🔝8868886958🔝Call Girl In Chandigarh N...
💚Reliable Call Girls Chandigarh 💯Niamh 📲🔝8868886958🔝Call Girl In Chandigarh N...
 

Len 1 rannazzisi

  • 1. Law  Enforcement  Track:   Rx  Drug  Inves9ga9ons  in  the   21st  Century   Presenter:  Joseph  T.  Rannazzisi,  JD,  RPh,   Deputy  Assistant  Administrator,  Office  of   Diversion  Control,  United  States  Drug   Enforcement  AdministraEon  (DEA)     Moderator:  Dan  Smoot,  CEO,  OperaEon  UNITE  
  • 2. I  have  no  financial  rela.onships  to  disclose     and   I  will  not  discuss  off-­‐label  use  and/or   inves.ga.onal  drug  use  in  my  presenta.on   Disclosure Statement U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 3.   Examine  reasons  for  the  increasing  rate  of  diversion  and  abuse  of   prescrip.on  narco.cs     Evaluate  effec.ve  strategies  for  drug  diversion  inves.ga.ons     Describe  the  opportuni.es  for  law  enforcement  agencies  to   collaborate  with  regulatory  agencies  during  drug  diversion   inves.ga.ons   Goals and Objectives U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 4. Responding to America’s Prescription Drug Abuse Crisis “When Two Addictions Collide” U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 5. U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 6. In  2010,  approximately  38,329  uninten9onal  drug   overdose  deaths  occurred  in  the  United  States,  one   death  every  14  minutes.     Of  this  number,  22,134  of  these  deaths  were   aNributed  to  Prescrip9on  Drugs  (16,651  aNributed   to  opioid  overdoses/  75.2  %).     Prescrip9on  drug  abuse  is  the  fastest  growing  drug   problem  in  the  United  States.   Source: CDC Drug Overdose Deaths in the United States, 2010 (October 2012) U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control         Consequences
  • 7. U.S. Drug Overdose Deaths by Major Drug Type, 1999-2010 Source: CDC/NCHS, NVSS U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 8. Drug-Induced Deaths vs. Other Injury Deaths, 1999–2009 Source: National Center for Health Statistics, Centers for Disease Control and Prevention. National Vital Statistics Reports Deaths: Final Data for the years 1999 to 2009 (January 2012). Causes  of  death  aGributable  to  drugs  include  accidental  or  inten.onal  poisonings  by  drugs  and  deaths  from  medical  condi.ons  resul.ng  from  chronic  drug  use.     Drug-­‐induced  causes  exclude  accidents,  homicides,  and  other  causes  indirectly  related  to  drug  use.    Not  all  injury  cause  categories  are  mutually  exclusive.   U.S.  Drug  Enforcement  Administra.on   Office  of  Diversion  Control        
  • 9. 2011 Current Users (Past Month) 2012    Source:  2011  &  2012  NSDUH  
  • 10. Prescription Drug Abuse More Americans abuse prescription drugs than the number of: Cocaine, Hallucinogen, Heroin, and Inhalant abusers U.S.  Drug  Enforcement  Administra.on   Office  of  Diversion  Control        
  • 11. Scope and Extent of Problem: Past Month Illicit Drug Use among Persons Aged 12 or Older Source: 2004, 2007, 2008, 2009, 2010, 2011, 2012 National Survey on Drug Use and HealthU.S.  Drug  Enforcement  Administra.on   Office  of  Diversion  Control        
  • 12. Source: 2011 National Survey on Drug Use and Health U.S.  Drug  Enforcement  Administra.on   Office  of  Diversion  Control         Percentage of Past Month Nonmedical Use of Psychotherapeutics by Age, 2003-2011
  • 13. SOURCE: 2012 National Survey on Drug Use and Health (NSDUH) published September 2013 by the Dept of HHS/ Substance Abuse and Mental Health Services Administration (SAMHSA) Past Year Initiates 2012 – Ages 12 and Older U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 14. Emergency Room Data 2004-2010 U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control         SOURCE: The DAWN Report, Highlights of the 2009 Drug Abuse Warning Network (DAWN) Findings on Drug-Related Emergency Department Visits, December 28, 2010
  • 15. SOURCE: 2012 National Survey on Drug Use and Health (NSDUH) published September 2013 by the Dept of HHS/ Substance Abuse and Mental Health Services Administration (SAMHSA) Substances for Which Most Recent Treatment Was Received in the Past Year among Persons Aged 12 or Older: 2012
  • 16. SOURCE: 2012 National Survey on Drug Use and Health (NSDUH) published September 03, 2013 by the Dept of HHS/ Substance Abuse and Mental Health Services Administration (SAMHSA) Substances for Which Most Recent Treatment Was Received in the Past Year among Persons Aged 12 or Older: 2002-2012
  • 17. Number of Forensic Cases 2001-2011 0   5,000   10,000   15,000   20,000   25,000   30,000   35,000   40,000   45,000   50,000   2001  2002  2003  2004  2005  2006  2007  2008  2009  2010  2011   240%     257%     U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control         322%    
  • 18. Poisoning Deaths: Opioid Analgesics *2009  data  approximated   *  
  • 19. Drug Overdose Mortality Rates per 100,000 People 1999 Source: Trust for America’s Health, www.healthyamericans.org. “Prescription Drug Abuse: Strategies to Stop the Epidemic (2013)” U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 20. Source: Trust for America’s Health, www.healthyamericans.org. “Prescription Drug Abuse: Strategies to Stop the Epidemic (2013)” Drug Overdose Mortality Rates per 100,000 People 2010 U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 21.  Most severe in Southwest and Appalachian  In 2010, the top three states were West Virginia, New Mexico, and Kentucky; West Virginia: 28.9 deaths per 100,000 New Mexico: 23.8 deaths per 100,000 Kentucky: 23.6 deaths per 100,000  Lowest-North Dakota: 3.4 deaths per 100,000  Minnesota ranked 47th 7.3 deaths per 100,000 Where Prescription Painkiller Overdose Deaths Are The Highest SOURCE: Trust for America’s Heath-Prescription Drug Abuse: Strategies To Stop The Epidemic; October 2013 U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 22. Naloxone     U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 23. Source:  U.S.  Census  Bureau   Statistical Perspective U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 24. Why is the problem outpacing population growth? U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 25. U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 26. In Florida two Westchase teachers learn a lesson: Say 'no' to mints in pill bottles U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control         The  drug  boGles  were  made  more   realis.c  with  labels  that  read  in  part:     “Watson’s  Whiz  Kid  Pharmacy.    Take  1   tablet  by  mouth  EVERY  5  MINUTES  to   cure  FCAT  jiGers.    Repeated  use  may   cause  crah  to  spontaneously  ooze   from  pores.    No  refills.    Ms.  Falcon’s   authoriza.on  required.”  
  • 27. Violence U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 28. Source: DEA Drug Theft & Loss Database as of 03/18/2014 Pharmacy Armed Robberies Rankings by State January 1 thru December 31, 2011 (691) U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 29. Pharmacy Armed Robberies Rankings by State January 1 thru December 31, 2012 (780) U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control         Source: DEA Drug Theft & Loss Database as of 03/18/2014
  • 30. Source: DEA Drug Theft & Loss Database as of 03/18/2014 Pharmacy Armed Robberies Rankings by State January 1 thru December 31, 2013 (692) U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 32. Violence Related to Controlled Substance Pharmaceuticals U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 33.  Eyewitness  News    MEDFORD  (WABC)  -­‐-­‐  The  suspect  in  the  Father's  Day  massacre  at  a  Long  Island   pharmacy  pleaded  guilty  to  murder  charges  Thursday.    David  Laffer  has  officially   withdrawn  his  not  guilty  pleas  to  charges  of  first-­‐degree  murder  and  criminal  use  of  a   firearm  and  waived  his  right  to  appeal.  Laffer  killed  four  people  at  Haven  Drugs  in   Medford  before  robbing  the  place  of  10,000  hydrocodone  pills.      Laffer's  wife,  Melinda  Brady,  also  pleaded  guilty  to  robbery  charges.  The  judge   announced  his  inten.on  to  sentence  Laffer  to  the  maximum  of  four  life  sentences  with   no  parole,  to  be  served  consecu.vely,  and  Brady  to  21  to  25  years  in  state  prison.   Formal  sentencing  for  both  husband  and  wife  is  scheduled  for  October  17.      Laffer  and  Brady  were  arrested  June  22  in  their  suburban  home  a  mile  and  a  half   from  Haven  Drugs,  where  authori.es  say  he  opened  fire  on  the  vic.ms  before   jamming  the  backpack  full  of  prescrip.on  painkillers.   U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control         Couple pleads guilty in pharmacy murders
  • 34. U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 35. 2 killed, 2 wounded in pharmacy shooting; ex-Bean Station officer to be charged By News Sentinel staff Knoxville News Sentinel Posted May 23, 2013 at 12:28 p.m., updated May 23, 2013 at 9:52 p.m. U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 36. Drug Education U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 37. Where do kids get their information from? U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 38.
  • 39.
  • 40.
  • 41.
  • 42. www.JustThinkTwice.com DEA Web-based Resources U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 43. www.GetSmartAboutDrugs.com DEA Web-based Resources U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 44. DEA Web-based Resources www.DEA.gov U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 45. U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 46. Community  Coali.ons  and   Advocacy  Groups   U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 47. Education  Pharmacists    Drug  Experts  in  the  health  care    delivery  system    Corresponding  responsibility   U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 48. Scheduled  PDACs   16-­‐Knoxville,  TN  March  22-­‐23,  2014   17-­‐St.  Louis,  MO  April  5-­‐6,  2014   18-­‐Phoenix,  AZ  June  28-­‐29,  2014   19-­‐Philadelphia,  PA  July  12-­‐13,  2014   20-­‐Denver,  CO  Aug  2-­‐3,  2014   21-­‐Salt  Lake  City,  UT  Aug  23-­‐24,  2014                                            FL    2              WA        UT        OR   CA    NV          ID        MT            AZ    WY    CO      NM ND SD                                TX                                                    4 NE KS                          OK   MN IA        MO AR LA MI WI      IL IN    6                    KY    TN      MS AL GA              3 OH            1  WV                        VA                  NC   SC PA                  NY                            5 MA ME DC   MD   NJ   CT   RI   DE   NH   VT   12 B 12A 18 21 20 7 11 10 17 9 14 8 16 15 13 19 Completed PDACs                      Scheduled PDACs February  11,  2014   Completed  PDACs                            AGendance   1-­‐Cincinna.,  OH    9/17-­‐18/11                   75   2-­‐WPB,  FL    3/17-­‐18/12                               1,192   3-­‐Atlanta,  GA  6/2-­‐3/12                             328   4-­‐Houston,  TX  9/8-­‐9/12                         518   5-­‐Long  Island,  NY  9/15-­‐16/12               391   6-­‐Indianapolis,  IN    12/8-­‐9/12                                    137   7-­‐Albuquerque,  NM  3/2-­‐3/13                            284   8-­‐Detroit,  MI  5/4-­‐5/13                               643   9-­‐Chicago,  IL    6/22-­‐23/13                               321   10-­‐Portland,  OR  7/13-­‐14/13                     242   11-­‐Baton  Rouge,  LA    8/3-­‐4/13       259   12A-­‐San  Diego,  CA  8/16-­‐17/13             353   12B-­‐San  Jose,  CA  8/18-­‐19/13                 434   13-­‐Boston,  MA  9/21-­‐22/13                         275   14-­‐Louisville,  KY  11/16-­‐17/13                 149   15-­‐CharloGe,  NC  2/8-­‐9/14   513              Total  AGendance       6,114  
  • 49. Law Enforcement Sponsored Training U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control         Health care professionals Community associations
  • 50. Most Frequent Method of Obtaining a Pharmaceutical Controlled Substance for Non- Medical Use Friends and Family…For Free!! U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 51. SOURCE: 2012 National Survey on Drug Use and Health (NSDUH) published September 3, 2013 by the Dept of HHS/ Substance Abuse and Mental Health Services Administration (SAMHSA) Source Where Pain Relievers Were Obtained for Most Recent Nonmedical Use Among Past Year Users Aged 12 or Older: 2011-2012
  • 52. U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 53. Medicine Cabinets: Easy Access More than half of teens (56%) indicate that it’s easy to get prescription drugs from their parent’s medicine cabinet Half of parents (495) say anyone can access their medicine cabinet More than four in 10 teens (42%) who have misused or abused a prescription drug obtained it from their parent’s medicine cabinet Almost half (49%) of teens who misuse or abuse prescription medicines obtained them from a friend Source: 2012 Partnership Attitude Tracking Study, published 4/23/13 U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 54. So Many Drugs in the Household – Why? Unreasonable quantities being prescribed Insurance rules U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 55. Law Enforcement Law  enforcement  officers,  ac9ng  to  enforce  laws  regarding  the   abandonment  of  controlled  substances,  may  receive  controlled   substances  from  ul9mate  users.   Law  enforcement  must  safeguard  the  controlled  substances  and   ensure  that  they  are  destroyed  properly.   Law  enforcement  must  be  present  during  the  destruc9on  of  the   controlled  substances.       U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 56. April  26,  2014   National Take Back Initiative April 26, 2014 U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control         10:00  AM  –  2:00  PM  
  • 57. On September 30, 2010, approximately 122 tons On April 30, 2011, approximately188 tons On October 29, 2011, approximately 189 tons On April 28, 2012, approximately 276 tons On September 29, 2012, approximately 244 tons On April 27, 2013, approximately 376 tons On October 26 , 2013, approximately 324 tons U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 58. National Take Back Day: October 26, 2013 Total Weight Collected (pounds): 647,211 (324 Tons) 8,153   10,880   5,527   10,030   17,077     MA   2,171   RI   4,603 CT   16,520   3,430   VT   5,343     NH   811   PR  &  VI   33,761   22,000   215   38,506   10,402   46,565   936   18,433   1,195   1,251   4,461   11,380   23,678   9,171   3,215   72,886   1,777   2,580     HI  &  GU    16,950     14,841 NJ   2,541   18,008   1,420   4,123   41,501   38,493   10,303   14,508   5,766   4,587   2,763   19,901   7,004   9,737   6,194   908   20,072   4,977   9,425 MD   974   DC   5,258   DE   U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 59. Prescription drug epidemic? How did we get to this point? U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 60. U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 61.
  • 62. The 1960s/70s/80s Downers  -­‐  Barbiturates   Uppers  -­‐  Amphetamines   Meprobamate   Hydromorphone   “Ts  and  Blues”   “Fours  and  Doors”   Oxycodone/APAP   methaqualone  
  • 63. U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control         The 1990s
  • 64. Hydrocodone AlprazolamOxycodone 30 mg Carisoprodol   OxyCon.n  80mg   Commonly Abused Controlled Pharmaceuticals Oxymorphone   C-­‐IV  as  of  1/11/2012  
  • 65. The Trinity C-­‐IV  as  of  1/11/2012   Hydrocodone   U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 66. U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 67. Most commonly prescribed prescription medicine? Hydrocodone/acetaminophen U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 68. Top Five Prescription Drugs Sold in the U.S. (2008-2011) U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control         Source:  IMS    Health,  Na.onal  Prescrip.on  Audit,  Updated  02/24/14      Millions  of   Prescrip.ons  
  • 69. State Ranking* - Hydrocodone January – September 2013 U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control         Source: Drug Enforcement Administration, Office of Diversion Control, Pharmaceutical Investigations Section, Targeting and Analysis Unit Most current ARCOS information as of March 18, 2014
  • 70. Approval of Single Entity Extended Release Hydrocodone U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 71. Source: Drug Enforcement Administration, Office of Diversion Control, Pharmaceutical Investigations Section, Targeting and Analysis Unit Most current ARCOS information as of March 18, 2014 State Ranking* - Oxycodone January – December 2013 U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 72. U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control         OxyContin Change
  • 73. New OxyContin® OP U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 74. Oxycodone 15mg/30mg Immediate Release U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 75. Opana ER (Schedule II)  Opana  ER  -­‐  (Schedule  II)   – Treats  constant,  around  the  clock,  moderate  to   severe  pain   – Becoming  popular  and  is  abused  in  similar  fashion   to  oxycodone  ;  August  2010  (Los  Angeles  FD  TDS)   – Slang:  Blues,  Mrs.  O,  Octagons,  Stop  Signs,  Panda   Bears   – Street:    $10.00  –  $80.00     U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 76. Source: Drug Enforcement Administration, Office of Diversion Control, Pharmaceutical Investigations Section, Targeting and Analysis Unit Most current ARCOS information as of March 18, 2014 State Ranking* - Oxymorphone January – December 2013 U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 77. Hydromorphone U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 78. Source: Drug Enforcement Administration, Office of Diversion Control, Pharmaceutical Investigations Section, Targeting and Analysis Unit Most current ARCOS information as of March 18, 2014 State Ranking* - Hydromorphone January – December 2013 U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 79. Opiates v. Heroin U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 80. Circle of Addiction & the Next Generation Hydrocodone   Lorcet®   $5-­‐$7/tab   Oxycodone   Combina.ons   Percocet®   $7-­‐$10/tab   OxyCon9n®   $80/tab   Heroin              $10/bag   Roxicodone®   Oxycodone  IR   15mg,  30mg   $30-­‐$40/tab   U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 81. HEROIN CASES and EXHIBITS National Forensic Laboratory Information System Year   #  Exhibits   #  Cases   2004   69,467   60,851   2005   73,569   64,471   2006   83,945   72,351   2007   82,408   69,850   2008   94,229   79,366   2009   107,272   87,249   2010   104,676   84,170   2011   109,049   86,513   2012   127,568   101,512   2013:  Jan  –  Jun   69,574   55,325   U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 82. Heroin  trafficking  organiza.ons  reloca.ng  to  areas  where   prescrip.on  drug  abuse  is  on  the  rise   Heroin  traffickers  pave  the  way  for  increasing  crime  and   violence   Law  enforcement  and  prosecutors  eventually  figh.ng  the   problem  on  two  fronts  (prescrip.on  opiate  diversion  and   heroin  distribu.on)  further  deple.ng  resources   Communi.es  suffer   Community Impact? U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 83. Where are the Pharmaceuticals Coming From?  Friends  and  Family  for  Free    Medicine  Cabinet    Doctor  Shopping    Internet    Pain  Clinics   U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 84. Methods of Diversion  Practitioners / Pharmacists –  Illegal distribution –  Self abuse –  Trading drugs for sex  Employee pilferage –  Hospitals –  Practitioners’ offices –  Nursing homes –  Retail pharmacies –  Manufacturing / distribution facilities  Pharmacy / Other Theft –  Armed robbery –  Burglary (Night Break-ins) –  In Transit Loss (Hijacking) –  Smurfing  Patients / Drug Seekers –  Drug rings –  Doctor-shopping –  Forged / fraudulent / altered prescriptions  The medicine cabinet / obituaries  The Internet  Pain Clinics U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 85. Prescription Fraud U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 86. Questions to Discuss    What  combina.on  of  drugs  is  referred  to  as  the  “trinity”?        A)    Hydrocodone,  alprazolam,  and  carisoprodol        B)    Promethazine  with  codeine,  methylphenidate  and                  carisoprodol        C)    Hydromorphone,  carisoprodol  and  buprenorphine        D)    Methadone,  diazepam  and  tramadol   U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 87. Doctor Shopping U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 88.
  • 89. Prescription Drug Monitoring Programs U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 90.
  • 91. Mandatory PDMP review before prescribing CS? U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 92. Standard of Care U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 93. National Association of Boards of Pharmacy U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 94. Diversion via the Internet U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 95. WA OR ID WY ND SD MN NE WI MI CO KS MO IL IN UT NV CA AZ NM OK AR LA TN KY MS AL GA SC NC OH VA PA NY ME V T N H CT DE WV RI MD MA Domestic ‘Rx’ Flow MTMT FL TX TX 2. Request goes through Website Server in San Antonio, TX WS FL IAIA NJ 1. Consumer in Montana orders hydrocodone on the Internet C 3. Web Company (located in Miami, FL) adds request to queue for Physician approval WC 4. Order is approved by Physician in New Jersey and returned to Web Company Dr. S 6. Pharmacy in Iowa fills order and ships to Consumer via Shipper Rx 5. Approved order then sent by Web Company to an affiliated Pharmacy
  • 96. New Felony Offense Internet Trafficking - 10/15/2008     21 USC 841(h)(1): It shall be unlawful for any person to knowingly or intentionally: (A) deliver, distribute, or dispense a controlled substance by means of the Internet, except as authorized by this title; or (B) aid or abet any violation in (A) U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 97. Per Se Violations  No in-person medical evaluation by prescribing practitioner  Online pharmacy not properly registered with modified registration.  Website fails to display required information U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 98. U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 99. Pain Clinics U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 100. Explosion of South Florida Pain Clinics As  of  June  4,  2010,  Florida  has  received  1,118  applica.ons  and  has  approved  1026   *As  of  May  14,  2010,  Broward  142;  Miami-­‐Dade  79;  Palm  Beach  111    U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 101. Hydrocodone Oxycodone 2002 9,376 8,288 2003 12,130 9,715 2004 16,401 13,492 2005 21,190 14,643 2006 24,984 17,927 2007 30,637 22,425 2008 33,731 28,756 2009 38,084 38,332 2010 39,444 48,210 2011 37,483 46,906 2012 35,140 42,869 2013* 26,844 31,897 NFLIS – Federal, State, and local cases reported U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control         NFLIS  Query  Date:  02/24/14  
  • 102. U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 103. U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 104. Medical Care ?  Many  of  these  clinics  are  prescrip.on/ dispensing  mills    Minimal  prac..oner/pa.ent  interac.on   U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 105. Increased Law Enforcement Pressure  Clinics  migra.ng  north  and  west    Funded  by  owners  in  Florida   U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 106. WASHINGTON OREGON CALIFORNIA NEVADA IDAHO MONTANA WYOMING UTAH ARIZONA NEW MEXICO COLORADO TEXAS OKLAHOMA KANSAS NEBRASKA SOUTH DAKOTA NORTH DAKOTA MINNESOTA IOWA MISSOURI ARKANSAS LOUIS. MISS. ALA. GEORGIA FLA. WISC. MICH. ILL. IND. OHIO PENN. N.Y. MAINE R.I. CONN. N.J. N.H. VT. MASS. W.V. DEL. MD. S.C. VIRGINIA N.C. KENTUCKY TENN. U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 107. WASHINGTON OREGON CALIFORNIA NEVADA IDAHO MONTANA WYOMING UTAH ARIZONA NEW MEXICO COLORADO TEXAS OKLAHOMA KANSAS NEBRASKA SOUTH DAKOTA NORTH DAKOTA MINNESOTA IOWA MISSOURI ARKANSAS LOUIS. MISS. ALA. GEORGIA FLA. WISC. MICH. ILL. IND. OHIO PENN. N.Y. MAINE R.I. CONN. N.J. N.H. VT. MASS. W.V. DEL. MD. S.C. VIRGINIA N.C. KENTUCKY TENN. U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 108. WASHINGTON OREGON CALIFORNIA NEVADA IDAHO MONTANA WYOMING UTAH ARIZONA NEW MEXICO COLORADO TEXAS OKLAHOMA KANSAS NEBRASKA SOUTH DAKOTA NORTH DAKOTA MINNESOTA IOWA MISSOURI ARKANSAS LOUIS. MISS. ALA. GEORGIA FLA. WISC. MICH. ILL. IND. OHIO PENN. N.Y. MAINE R.I. CONN. N.J. N.H. VT. MASS. W.V. DEL. MD. S.C. VIRGINIA N.C. KENTUCKY TENN. U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 109. WASHINGTON OREGON CALIFORNIA NEVADA IDAHO MONTANA WYOMING UTAH ARIZONA NEW MEXICO COLORADO TEXAS OKLAHOMA KANSAS NEBRASKA SOUTH DAKOTA NORTH DAKOTA MINNESOTA IOWA MISSOURI ARKANSAS LOUIS. MISS. ALA. GEORGIA FLA. WISC. MICH. ILL. IND. OHIO PENN. N.Y. MAINE R.I. CONN. N.J. N.H. VT. MASS. W.V. DEL. MD. S.C. VIRGINIA N.C. KENTUCKY TENN. U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 110. WASHINGTON OREGON CALIFORNIA NEVADA IDAHO MONTANA WYOMING UTAH ARIZONA NEW MEXICO COLORADO TEXAS OKLAHOMA KANSAS NEBRASKA SOUTH DAKOTA NORTH DAKOTA MINNESOTA IOWA MISSOURI ARKANSAS LOUIS. MISS. ALA. GEORGIA FLA. WISC. MICH. ILL. IND. OHIO PENN. N.Y. MAINE R.I. CONN. N.J. N.H. VT. MASS. W.V. DEL. MD. S.C. VIRGINIA N.C. KENTUCKY TENN. U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 111. WASHINGTON OREGON CALIFORNIA NEVADA IDAHO MONTANA WYOMING UTAH ARIZONA NEW MEXICO COLORADO TEXAS OKLAHOMA KANSAS NEBRASKA SOUTH DAKOTA NORTH DAKOTA MINNESOTA IOWA MISSOURI ARKANSAS LOUIS. MISS. ALA. GEORGIA FLA. WISC. MICH. ILL. IND. OHIO PENN. N.Y. MAINE R.I. CONN. N.J. N.H. VT. MASS. W.V. DEL. MD. S.C. VIRGINIA N.C. KENTUCKY TENN. U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 112. WASHINGTON OREGON CALIFORNIA NEVADA IDAHO MONTANA WYOMING UTAH ARIZONA NEW MEXICO COLORADO TEXAS OKLAHOMA KANSAS NEBRASKA SOUTH DAKOTA NORTH DAKOTA MINNESOTA IOWA MISSOURI ARKANSAS LOUIS. MISS. ALA. GEORGIA FLA. WISC. MICH. ILL. IND. OHIO PENN. N.Y. MAINE R.I. CONN. N.J. N.H. VT. MASS. W.V. DEL. MD. S.C. VIRGINIA N.C. KENTUCKY TENN. U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 113. WASHINGTON OREGON CALIFORNIA NEVADA IDAHO MONTANA WYOMING UTAH ARIZONA NEW MEXICO COLORADO TEXAS OKLAHOMA KANSAS NEBRASKA SOUTH DAKOTA NORTH DAKOTA MINNESOTA IOWA MISSOURI ARKANSAS LOUIS. MISS. ALA. GEORGIA FLA. WISC. MICH. ILL. IND. OHIO PENN. N.Y. MAINE R.I. CONN. N.J. N.H. VT. MASS. W.V. DEL. MD. S.C. VIRGINIA N.C. KENTUCKY TENN. U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 114. WASHINGTON OREGON CALIFORNIA NEVADA IDAHO MONTANA WYOMING UTAH ARIZONA NEW MEXICO COLORADO TEXAS OKLAHOMA KANSAS NEBRASKA SOUTH DAKOTA NORTH DAKOTA MINNESOTA IOWA MISSOURI ARKANSAS LOUIS. MISS. ALA. GEORGIA FLA. WISC. MICH. ILL. IND. OHIO PENN. N.Y. MAINE R.I. CONN. N.J. N.H. VT. MASS. W.V. DEL. MD. S.C. VIRGINIA N.C. KENTUCKY TENN. U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 115. U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 116. Drugs Prescribed  A  ‘cocktail’  of  oxycodone  and  alprazolam  (Xanax)    An  average  ‘pa.ent’  receives  prescrip.ons  or   medica.ons  in  combina.on   Schedule  II   Schedule  III   Schedule  IV   Oxycodone  15mg,  30mg   Vicodin  (Hydrocodone)   Xanax  (Alprazolam)   Roxicodone  15mg,  30mg     Lorcet   Valium  (Diazepam)   Percocet   Lortab   Percodan   Tylenol  #3  (codeine)   Demerol   Tylenol  #4  (codeine)   Methadone   U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 117. Average Charges for a Clinic Visit  Price varies if medication is dispensed or if customers receive prescriptions  Some clinics advertise in alternative newspapers citing discounts for new patients such as 'buy one get one free‘ or “50% off with this ad”  Typically, initial office visit is $250 or more; each subsequent visit may exceed $200  Prescriptions average 120-180 30mg oxycodone tablets per visit U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 118. Cost of Drugs  According  to  medical  experts,  most  clinics  do  not   require  sufficient  medical  history  and  tests  for  proper   prescribing  of  Schedule  II  substances    Oxycodone  30mg  immediate  release  tablets  cost     approximately  $30.00  to  $40.00  per  tablet  on  the  street   depending  on  the  sale  loca.on  in  the  U.S.  ($1  per  mg  or   more)   U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 119. U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 120. What’s the Profit? U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 121. What’s the Profit? U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 122. What’s the Profit? U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 123. Florida Pain Clinic Raid U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 124. U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 125. U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 126. U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 127. U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 128. U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 129. U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 130. U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 131. U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 132. U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 133. U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 134. U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 135. U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 136. U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 137. U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 138. U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 139. U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 140. U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 141. U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 142. U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 143. U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 144. U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 145. U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 146. U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 148. Foreign Mfr Importer Manufacturer Distri- butor Practitioner Pharmacy Hospital Clinic Patient ? Law:  21  USC  822    (a)  (1)  Persons  Required  to  Register:   “Every  person  who  manufactures  or  distributes  any  Controlled  Substance  or  List  I   Chemical  or  who  proposes  to  engage  in  ..”   Law:  21  USC  822  (a)  (2)  Persons  Required  to  Register:   “Every  person  who  dispenses,  or  who  proposes  to  dispense  any     controlled  substance  ...”  
  • 150. 150   U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 151. The Flow of Pharmaceuticals PATIENTS Hospitals NTPs 21 CFR 1306.04 Physicians (Rx and drugs) Pharmacies QUOTASRaw Material Importers Imp - Manufacturers 21 USC 823(c)(1) 21 USC 823(d)(1) 21 CFR 1301.71 Dosage Form Manufacturers Manufacturers Dosage Form Manufacturers 21 USC 823(b)(1) 21 USC 823(e)(1) 21 CFR 1301.71 21 CFR 1301.74 (Suspicious Orders) Wholesalers - DistributorsSmaller Distributors U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 152. Diversion via the Internet U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 153. WA OR ID WY ND SD MN NE WI MI CO KS MO IL IN UT NV CA AZ NM OK AR LA TN KY MS AL GA SC NC OH VA PA NY ME V T N H CT DE WV RI MD MA Domestic ‘Rx’ Flow MTMT FL TX TX 2. Request goes through Website Server in San Antonio, TX WS FL IAIA NJ 1. Consumer in Montana orders hydrocodone on the Internet C 3. Web Company (located in Miami, FL) adds request to queue for Physician approval WC 4. Order is approved by Physician in New Jersey and returned to Web Company Dr. S 6. Pharmacy in Iowa fills order and ships to Consumer via Shipper Rx 5. Approved order then sent by Web Company to an affiliated Pharmacy U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 154. Purchases of hydrocodone by Known and Suspected Rogue Internet Pharmacies January 1, 2006 – December 31, 2006 Date  Prepared:      03/07/2007  Source:    ARCOS   98,566,711
  • 155. Checks and Balances of the CSA and the Regulatory Scheme   Distributors of controlled substances “The registrant shall design and operate a system to disclose to the registrant suspicious orders of controlled substances…Suspicious orders include orders of unusual size, orders deviating substantially from a normal pattern, and orders of unusual frequency.” (21 CFR §1301.74) U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 156. DEA  Distributor  Ini9a9ve     Purpose and format:   Educate and inform distributors/manufacturers of their due diligence responsibilities under the CSA by discussing their Suspicious Order Monitoring System, reviewing their ARCOS data for sales and purchases of Schedules II and III controlled substances, and discussing national trends involving the abuse of prescription controlled substances   August 2005 – Present: Briefings to 83 firms with 276 locations Examples of civil action against distributors: Cardinal Health , $34 million civil fine McKesson, $13.25 million civil fine Harvard, $6 million civil fine Examples of suspension, surrender or revocation of DEA registration Keysource, loss of DEA registration Sunrise, loss of DEA registration U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 157. Source:  www.kuow.org  ,   01/30/2014   John Gray, president and CEO of Healthcare Distribution Management Association, said suppliers used to have a more cooperative and collaborative relationship with the Drug Enforcement Agency. But things have changed, he said. “It’s all been dumped in our laps as wholesalers to make what I would consider to be law enforcement decisions as to whether or not a particular customer or account is or is not over what the DEA, in their own mind, thinks is a viable limit for Schedule II drugs they ought to be dispensing,” Gray said. U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 158.
  • 159. “At  the  .me  we  filled  these  orders,  the  pharmacies  held  valid  state     board  of  pharmacy  and  DEA  licenses,”  BarreG  said  in  a  call  to  investors  on   Friday.  “Pharmaceu.cal  distributors  do  not  influence  the  manufacture  of   controlled  medicines.  We  do  not  write  prescrip.ons.  We  do  not  dispense   controlled  medicines,  nor  do  we  license  pharmacies.  Our  role  is,  as  a   distributor,  a  cri.cal  link  in  the  supply  chain  between  pharmaceu.cal   manufacturers  and  pharmacies.  “      Cardinal  CEO  George  BarreG   The  Company  called  the  DEA  ac.on    “a  dras.c  overreac.on”   that  would  disrupt  delivery  of  cri.cal  medica.ons  to     hospitals  and  pharmacies.  
  • 160. Misleading  Title?   Sponsored  by   Reps  from  TN,   PA,  CO,    and  GA   This  bill  effec.vely  eliminates  the  DEA’s   administra.ve  powers  of  the  OTSC  and  ISO   op.ons,  and  instead  requires  DEA  to  give   no.ce  and  offer  the  registrant  an  opportunity   to  submit  a  correc.ve  ac.on  plan.   An  ISO  is  issued  to  protect  the  public  from   imminent  harm.    By  redefining  an  ISO  and   delaying  it’s  issuance,  the  bill  would  prevent   the  DEA  from  protec.ng  the  public  when  harm   is  imminent.   DEA  conducts  more  5,000  inspec.ons  on   registrants  yearly  and  takes  administra.ve   ac.on  on  a  very  small  percentage  of  those   registrants  inspected.  
  • 161. DEA Imposed Quotas on Wholesalers/ Distributors of Controlled Substances to downstream customers? NO! U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 162. Checks and Balances Under the CSA •  Practitioners “A prescription for a controlled substance to be effective must be issued for a legitimate medical purpose by an individual practitioner acting in the usual course of professional practice.” (21 CFR §1306.04 (a)) United States v Moore 423 US 122 (1975) U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 163. The Controlled Substances Act Illegal Distribution 21 U.S.C. § 841 (a) Unlawful acts: Except as authorized by this subchapter, it shall be unlawful for any person to knowingly or intentionally (1) to manufacture, distribute or dispense, or possess with intent to manufacture, distribute or dispense, a controlled substance; or U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 164. The Last Line of Defense U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 165. Checks and Balances Under the CSA Pharmacists – The Last Line of Defense “The responsibility for the proper prescribing and dispensing of controlled substances is upon the practitioner, but a corresponding responsibility rests with the pharmacist who fills the prescription.” (21 CFR §1306.04(a)) U.S v. Hayes 595 F. 2d 258 (5th Cir 1979) U.S. v. Leal 75 F. 3d 219 (6th Cir 1996) U.S. v. Birbragher 603 F. 3d 478 (8th Cir 2010) East Main Street Pharmacy 75 Fed. Reg. 66149 (Oct. 27, 2010) U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 166. Checks and Balances Under the CSA Pharmacists – The Last Line of Defense “An order purporting to be a prescription issued not in the course of professional treatment or in legitimate and authorized research is not a prescription within the meaning and intent of section 309 of the act (21 USC 829) and the person knowingly filling such a purported prescription, as well as the person issuing it, shall be subject to the penalties provided for violations of the provisions of law relating to controlled substances.” (21 CFR §1306.04(a)) U.S v. Hayes 595 F. 2d 258 (5th Cir 1979) U.S. v. Leal 75 F. 3d 219 (6th Cir 1996) U.S. v. Birbragher 603 F. 3d 478 (8th Cir 2010) East Main Street Pharmacy 75 Fed. Reg. 66149 (Oct. 27, 2010) U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 167.  When  prescrip.ons  are  clearly  not   issued  for  legi.mate  medical  purposes,  a   pharmacist  may  not  inten.onally  close  his   eyes  and  thereby  avoid  [actual]  knowledge   of  the  real  purpose  of  the  prescrip.ons.     (Ralph  J.  Bertolino,  55  FR  4729,  4730   (1990)),    
  • 168. Corresponding Responsibility Cases U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 169. What  happens  next?   You  aGempt  to  resolve…   U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 170. Resolution is comprised of many factors Verifica.on  of  a  valid  prac..oner  DEA  number    is  required!    It  is  not,   however,  the  end  of  the  pharmacists  duty.    Invalid  RX   Resolu.on  cannot  be  based  solely  on  pa.ent  ID  and  prescriber   verifica.on.       You  must  use  your  professional    judgment,  training  and  experience…we   all  make  mistakes   Knowledge    and  history  with  the  pa.ent   Circumstances  of  prescrip.on  presenta.on   Experience  with  the  prescribing  prac..oner   It  does  not  require  a  call  to  the  prac..oner  for  every  CS  RX   This  is  not  an  all-­‐inclusive  list…   U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 171. Many  customers  receiving  the  same  combina.on  of  prescrip.ons;  cocktail   Many  customers  receiving  the  same  strength  of  controlled  substances;  no   individualized  dosing:  mul.ple  prescrip.ons  for  the  strongest  dose   Many  customers  paying  cash  for  their  prescrip.ons   Early  refills   Many  customers  with  the  same  diagnosis  codes  wriGen  on  their  prescrip.ons;   Individuals  driving  long  distances  to  visit  physicians  and/or  to  fill  prescrip.ons;     U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 172. Customers  coming  into  the  pharmacy  in  groups,  each  with  the  same   prescrip.ons  issued  by  the  same  physician;  and   Customers  with  prescrip.ons  for  controlled  substances  wriGen  by  physicians  not   associated  with  pain  management  (i.e.,  pediatricians,  gynecologists,   ophthalmologists,  etc.).   Overwhelming  propor.on  of  prescrip.ons  filled  by  pharmacy  are  controlled   substances   Pharmacist  did  not  reach  out  to  other  pharmacists  to  determine  why  they  were   not  filling  a  par.cular  doctors  prescrip.on   Verifica.on  of  legi.macy  not  sa.sfied  by  a  call  to  the  doctors  office   U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 173. AMA View on Corresponding Responsibility U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control         Inquiries  by  pharmacists  with  doctors  regarding  the  ra.onale  behind         prescrip.ons,  diagnoses    and  treatment  plans  are  inappropriate.    These  inquiries  are   “an  interference  with  the  prac.ce  of  medicine  and  unwarranted”.  
  • 174. U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 175. Purchases of Oxycodone 30mg  In  2009,    44%  of  all  oxycodone  30mg  products   were  distributed  to  Florida    In  2010,    43%  of  all  oxycodone  30mg  products   were  distributed  to  Florida   U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 176. Remaining  States   593,625,290  dosage  units   Florida   94,923,484  dosage  units   Source:    ARCOS     Date  Prepared:      01/30/2014   U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 177. Florida   94,923,484  dosage  units   New  York   50,658,100  dosage   units   Remaining  States   486,977,390  dosage  units   California   55,989,800  dosage   units   Source:    ARCOS     Date  Prepared:      01/30/2014   U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 178. Viola.ons?   What  happens  next…..  
  • 179. DEA Legal Recourse  Administra.ve                        Immediate  Suspension  Order  (ISO)                        Memorandum  of  Agreement  (MOA)                        Order  to  Show  Cause  (OTSC)    Civil                        Fines    Criminal                        Tac.cal  Diversion  Squads     U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 180. How Do You Lose Your Registration? The  Order  to  Show  Cause  Process    21  USC  §  824   a)  Grounds  –     1.  Falsifica.on  of  Applica.on   2.  Felony  Convic.on   3.  State  License  or  Registra.on  suspended,  revoked  or  denied  –   no  longer  authorized  by  State  law   4.  Inconsistent  with  Public  Interest   5.  Excluded  from  par.cipa.on  in  Title  42  USC  §  1320a-­‐7(a)   program   b)        AG  discre.on,  may  suspend  any  registra.on  simultaneously   with  Order  to  Show  Cause  upon  a  finding  of  Imminent  Danger  to   Public  Health  and  Safety    
  • 181. * FY2014 as of February 27, 2014 AdministrativeActions Initiated by DEA FY2007thru2014* U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 182. Initiation of Investigation U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 183. ARCOS PDMP     U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 184.  Inves9ga9ng  Physicians   • “Outside the Scope” –  CFR and Case Law: “A prescription for a controlled substance to be effective must be issued for a legitimate medical purpose by an individual practitioner acting in the usual course of his professional practice.” –  “In accordance with the standard of medical practice generally recognized and accepted in the US.” Once outside the scope => 21 USC 841 U.S. Drug Enforcement Administration / Operations Division / Office of Diversion Control Legal Basis
  • 185. Standards  of  Care-­‐State  Boards   U.S. Drug Enforcement Administration / Operations Division / Office of Diversion Control
  • 186. Inves9ga9ng  Physicians   Targeting sources: –  Referrals from medical/pharmacy boards –  Law enforcement agency partners –  Confidential Sources –  Liaison: •  Hospitals (ER staff) •  Medical examiners •  Treatment /Rehab facilities •  Pharmacies (PICs and security staff) –  Choicepoint and other commercially available databases U.S. Drug Enforcement Administration / Operations Division / Office of Diversion Control Targeting/Evaluation
  • 187. Interviews of sources (patients, former employees) –  Look for Patterns and RED FLAGS: •  Relatively large quantities of controlled substances •  Little or no medical exam or diagnostic exams •  Cash-only practice •  No referrals to specialist for treatment or evaluation •  Pain “cocktails” •  Patients live long distances from practice •  Long lines of waiting patients •  Patients show indications of addiction •  Directed patients to specific pharmacies U.S. Drug Enforcement Administration / Operations Division / Office of Diversion Control Evaluation/Red Flags Inves9ga9ng  Physicians  
  • 188. Dr.    Bamdad,  Los   Angeles     Fugitive Pill Mill Doctor (Dr. Robert Ignasiak) Who Faked Suicide Found and Arrested in South Florida
  • 189. 189  
  • 190. Perfunctory  ini.al  physical  exam…return  visits  no  exam   Physical  exam  included  needle  mark  checks…some  were  simulated   Pa.ent  received  quan.ty  of  drugs  requested…were  charged  based   on  quan.ty   Unsupervised  urinalysis  –  results  did  not  maGer   Accurate  records  not  kept  –  quan.ty  dispensed  not  recorded   Prac..oner  not  authorized  to  conduct  methadone  maintenance;   Pa.ent  directed  prescribing;     U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 191. Rosen  was  a  68  yo  physician  who  had  a  prac.ce  that  was  focused  on  obesity.  He   dispensed  large  quan..es  of  s.mulants  to  undercover  officers    outside  the   scope  and  not  for  a  legi.mate  purpose.       The  5th  circuit  had  to  address  whether  the  medica.on  was  dispensed  “for  a   legi.mate  medical  purpose  and  in  the  course  of  the  doctors  professional   prac.ce.”    In  its  analysis,  the  court  stated,  “We  are  however,  able  to  glean   from  reported  cases,  certain  recurring  concomitance  of  condemned   behavior,  examples  of  which  include  the  following:     An  inordinately  large  quan.ty  of  controlled  substances  prescribed   Large  numbers  of  prescrip.on  were  issued   No  physical  exam  given   The  physician  warned  the  pa.ent  to  fill  prescrip.ons  at  different    drug  stores   U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 192. Customers  coming  into  the  pharmacy  in  groups,  each  with  the  same   prescrip.ons  issued  by  the  same  physician;  and   Customers  with  prescrip.ons  for  controlled  substances  wriGen  by  physicians  not   associated  with  pain  management  (i.e.,  pediatricians,  gynecologists,   ophthalmologists,  etc.).   Overwhelming  propor.on  of  prescrip.ons  filled  by  pharmacy  are  controlled   substances   Pharmacist  did  not  reach  out  to  other  pharmacists  to  determine  why  they  were   not  filling  a  par.cular  doctors  prescrip.on   Verifica.on  of  legi.macy  not  sa.sfied  by  a  call  to  the  doctors  office   U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 193. The  physician  issued  prescrip.ons  to  a  pa.ent  known  to  be  delivering  the  drugs  to   others   The  physician  prescribed  controlled  drugs  at  intervals  inconsistent  with  legi.mate   medical  treatment   The  physician  involved  used  street  slang  rather  than  medical  terminology  for  the  drugs   prescribed   There  was  no  logical  rela.onship  between  the  drug  prescribed  and  treatment  of  the   condi.on  allegedly  exis.ng   The  physician  wrote  more  than  one  prescrip.on  on  occasions  in  order  to  spread  them   out   U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 194. Pa.ents  receiving  the  same  combina.on  of  prescrip.ons;  cocktail   Pa.ents  receiving  the  same  strength  of  controlled  substances;  no  individualized   dosing:  mul.ple  prescrip.ons  for  the  strongest  dose   Majority  of  pa.ents  paying  cash  for  their  prescrip.ons   Pa.ent  directed  prescribing;  pa.ent  asks  for  drugs  in  street  slang   Early  refills   No  specialized  training  in  pain  management;   Individuals  driving  long  distances  to  visit  physicians  and/or  to  fill  prescrip.ons   No  records/pa.ent  contracts/  urinalysis     U.S.  Drug  Enforcement  Administra.on    Office  of  Diversion  Control        
  • 195. Initial verification/corroboration –  Prescription Monitoring Programs-30 day look –  Look for legitimate explanations of activity –  Physical surveillance-Video •  Patient traffic inside/outside clinic •  Staff removing records/bags from office •  MD/staff visiting banks –  Database checks; prior/related investigations –  Crosscheck with other agencies for related information •  Professional state licensing boards-Discipline/on-going investigations U.S. Drug Enforcement Administration / Operations Division / Office of Diversion Control Initial Evaluation Inves9ga9ng  Physicians  
  • 196. Inves9ga9ng  Physicians     Considerations –  DON’T TRICK THE DOCTOR –  Intent: evidence of “outside the scope” –  Video/Audio recording crucial –  Pain mention- not always a show stopper –  MRI/Medical records- creating/patterns of use –  Frequency of visits-multiple undercovers –  Street slang/prices/conversation –  Meet other patients in clinic –  Medication prescribed for others not present –  ASK: specific drugs/increase doses/multiple scripts U.S. Drug Enforcement Administration / Operations Division / Office of Diversion Control Undercover Process
  • 197. Inves9ga9ng  Physicians   Grand Jury Subpoenas –  Banks- Laundering and asset identification Expert Review –  Establish Probable Cause for Search warrant/Administrative action –  PMP records –  Reports: Undercover, Interviews of patients/employees –  UC video/audio –  Opinion: “Extreme departure” from standards –  Sources: Professional boards/associations, teaching universities. U.S. Drug Enforcement Administration / Operations Division / Office of Diversion Control Investigative Process
  • 198. Inves9ga9ng  Physicians   Timing of search and arrests-considerations –  Public safety –  Rush to Indictment following arrest-be prepared –  Loss of assets –  High profile defendant-Press/political interests –  Immediate suspension of DEA registration/state licensing action Processing medical records –  Know what you’re looking for Expert Review of seized medical records Patient and employee interviews U.S. Drug Enforcement Administration / Operations Division / Office of Diversion Control Search Warrants
  • 199. Inves9ga9ng  Physicians   Search warrants/affidavits –  Get a go-by –  Include: type of drugs, case law/statute of legitimate prescribing, medical standards, how target violated standard, expert opinion, specific records to seize, how to conduct search –  Special masters not usually required in fed cases –  Plan how to process and store records –  Request computer forensic/doc exploitation teams –  Electronic scanning/prosecution preference U.S. Drug Enforcement Administration / Operations Division / Office of Diversion Control Search Warrant Mechanics
  • 200. Inves9ga9ng  Physicians Appropriate Jurisdiction:  Federal/State (Attorney General)/District Attorney’s Office –  Offenses/charging/burdens/sentences all vary Death enhancements –  Medical examiner investigation –  Cause of death/documentation –  Multiple Expert opinions Other enhancements - Distances/under age 21 Charging: UC counts/Relative conduct at sentencing –  Medical fraud considerations Asset Forfeiture - Criminal/civil/administrative U.S. Drug Enforcement Administration / Operations Division / Office of Diversion Control Prosecution  
  • 201. Inves9ga9ng  Pharmacies   •  Corresponding Responsibility – Unlawful Distribution Title 21 USC 841 (a)(1)/846 •  Evidence exists that pharmacist/owner delivered drugs to (an) individual (s) pursuant to (an) unlawful order(s) (prescription). A “rogue” physician is typically involved. •  Pharmacist knew or should have known that the prescription was illegal (issued outside the course of a professional practice.) Examples: Prescription was issued in the course of an UC operation in exchange for cash; rx has obvious inadequacies, excessive dosages or quantities, refills at an uncommonly high rate or indications of customer misuse of the drug. •  Use of Expert Witness – Pharmacists or Doctors are usually called upon to examine prescriptions and pharmacy records to aid in determining if the pharmacist exercised corresponding responsibility. 201  U.S. Drug Enforcement Administration / Operations Division / Office of Diversion Control Legal Basis  
  • 202. Inves9ga9ng  Pharmacies   •  Unlawful Distribution –Unlawful Distribution Title 21 USC 841 (a)(1)/846 •  Evidence exists that pharmacist delivered a drug without a lawful order (issued outside the course of a professional practice). •  Atypical to this case is the lack of physician involvement. For example, UC operation details the pharmacist delivering drugs to CS/UC in exchange for cash, and solicits CS/UC for fraudulent rxs to cover up the diversion of drugs from the pharmacy. (See Tampa case S/S Pharmacy, Federal register notice dated 9/19/2013). 202   Legal Basis U.S. Drug Enforcement Administration / Operations Division / Office of Diversion Control
  • 203. Inves9ga9ng  Pharmacies   • Health Care Fraud – •  31 U.S.C. 3729(a)(1)(A)(B): When a person knowingly makes a false claim to receive payment from the government. •  There must be evidence that the pharmacist filled a prescription and billed medical insurance providers knowing the prescriptions were not written for a legitimate medical purpose. 203   Legal Basis U.S. Drug Enforcement Administration / Operations Division / Office of Diversion Control
  • 204. Inves9ga9ng  Pharmacies   •  Chain Pharmacies- •  Pharmacy which has national exposure: CVS; Rite Aid; Walgreens, etc. •  Typically targeted for civil prosecution (fines). •  Must be coordinated with DEA HQS ODG prior field contact with US Attorney. •  Targeted pharmacy has numerous CSA violations (21 CFR 1300 to end) which led to facilitation of drug diversion. 204   Legal Basis U.S. Drug Enforcement Administration / Operations Division / Office of Diversion Control
  • 205. Inves9ga9ng  Pharmacies   • Sources of Information - Supplier/Distributor, Suspicious Order Reports, Pharmacy Boards, Medical Examiners, Police Departments, Tips from citizens, ARCOS, PDMP • Spin-off cases – Medical Doctor, distributor investigations • Informants - Included in routine narcotics debriefings. Cooperating defendants/individuals. • Government Agencies - Joint investigations with agencies such as FBI, HHS, FDA, Homeland Security, Medical/Pharmacy Boards, etc. • Drug Overdose Investigation - Check of Police Report of OD deaths in area to compare to pharmacy prescription history. What Triggers a Pharmacy Investigation 205  U.S. Drug Enforcement Administration / Operations Division / Office of Diversion Control
  • 206. Inves9ga9ng  Pharmacies   • Profiles - Check ARCOS, PDMP, NADDIS, NCIC, Pharmacy Board, ChoicePoint, CLEAR, Police Department activity reports. • Industry reports - DEA-106s, DEA-41s, Check distributor customer report. • Surveillance - Observation of pharmacy activity, focus on video recordings of suspicious individuals, vehicles (out of state plates), parking lot hand exchanges, volume of customers in parking lot waiting to enter facility. • Customer base – Review PMP data, identify primary source physicians and patient profiles (age, types of drugs, distance from residence, etc) 206   Conduct Background Investigation U.S. Drug Enforcement Administration / Operations Division / Office of Diversion Control
  • 207. Ringleader Robin Steinke   Pharmacist Jeff Clawson   CVS Pharmacy, Inc. Agrees to $11 Million Settlement for Violations of the Controlled Substances Act Large National Chain Pharmacy First Ever DEA Registration Revocation TDS Dismantles Oxycodone Trafficking Group and Arrests Pharmacist PlaNe  Valley  Pharmacy  in  Brighton,  Colorado   Sanford,  FL,  CVS    
  • 208.
  • 209. Inves9ga9ng  Pharmacies   • Vehicle Stops - Stops of multiple customers may reveal drug prescription information, doctor information, drug type, drug quantities, patient information, develop confidential informants. Criminal checks based on vehicle registrations. Travel from afar? Follow to storage sites. Organized vehicle stops with Police. • Undercover Operations - Undercover buys may reveal pharmacy illegal procedures, CSA violations, pharmacy/tech/owner conspiratorial members. Consensual phone calls by informant(s) to pharmacist. • Trash searches - May produce evidence for search warrants. May also identify information regarding additional warehouses, banking information, additional addresses, discarded scripts, etc. 209   Evidence Gathering Techniques U.S. Drug Enforcement Administration / Operations Division / Office of Diversion Control
  • 210. Inves9ga9ng  Pharmacies   • Video - Review any available video from inside pharmacy, consider obtaining court order to bug pharmacy. • Financial Check - Conduct financial investigation on pharmacist to uncover unusual large cash deposits, bank accounts, associated assets. •  Purpose of investigative methods will aid in establishing probable cause for a search warrant and identify conspirators. 210   Evidence Gathering Techniques (cont’d.) U.S. Drug Enforcement Administration / Operations Division / Office of Diversion Control
  • 211. Inves9ga9ng  Pharmacies   • Criminal Actions - Determine if evidence exists to prove the following statutes: •  21 U.S.C. 841(a)(1) – Illegal Distribution •  21 U.S. C. 843(a)(3) – To acquire or obtain possession of a controlled substance by misrepresentation, fraud, forgery, deception or subterfuge • Civil Actions - Determine if there is a preponderance of evidence indicating a violation of the following statutes: •  21 U.S.C. 842(a)(1) – Dispensing outside the course of normal practice •  21 U.S. C. 842(a)(5) – Violation of CSA, recordkeeping and reporting requirements (Title 21 CFR 1300 to end).   211   Review Case to determine applicable Administration, Civil or Criminal Actions U.S. Drug Enforcement Administration / Operations Division / Office of Diversion Control
  • 212. Inves9ga9ng  Pharmacies   • Administrative - Immediate Suspension Order/Order to Show Cause- Determine if grounds exists under the following factors: • (1) The recommendation of the appropriate State licensing board or professional disciplinary authority: license revocation/suspension; admin findings relating to drug violations, etc. • (2) The applicant's experience in dispensing, or conducting research with respect to controlled substances: unlawful drug distribution; health care fraud conviction, etc. • (3) The applicant's conviction record under Federal or State laws relating to the manufacture, distribution, or dispensing of controlled substances. • (4) Compliance with applicable State, Federal, or local laws relating to controlled substances. • (5) Such other conduct which may threaten the public health and safety. • *Need one or more factor to recommend OTSC/ISO action. 212   Review Case to determine applicable Administration, Civil or Criminal Actions (cont’d.) U.S. Drug Enforcement Administration / Operations Division / Office of Diversion Control
  • 213. • Other Administrative Actions - Determine if violations of Title 21 CFR 1300 to end: •  Memorandum of Agreement (MOA) – Specifies terms of registrant’s future compliance. Violation of terms is grounds for an OTSC. •  Letter of Admonition (LOA) – Notifies the registrant in writing of CSA violations and requires that he/she remedies same. •  Investigative Warning – Investigator advises registrant of CSA violations and requires that he/she remedies same. Note: Controlled Substance Act of 1970 outlines regulations for registrants regarding the proper handling of controlled substances. Violations of this act are usually remedied through civil/administrative actions Inves9ga9ng  Pharmacies   213   Review Case to determine applicable Administration, Civil or Criminal Actions (cont’d.) U.S. Drug Enforcement Administration / Operations Division / Office of Diversion Control
  • 214. Inves9ga9ng  Pharmacies   • Search Warrant - Handled the same as normal search warrants but are usually executed without force. • Administrative Inspection Warrant (AIW) - •  Issued by a Federal Magistrate. •  Limited to records required to be kept under 21 CFR 1300 to end. Examples: Order Forms, Invoices, prescriptions, inventories, etc. •  Has to be conducted during business hours in a professional manner. •  Notice of Inspection (DEA Form – 82) – •  Issued by assigned Agent/Investigator/TFO (deputized) •  Limited to required records relating to 21 CFR 1300 to end. •  Only copies can be taken without consent. 214   Methods of obtaining pharmacy documentary evidence U.S. Drug Enforcement Administration / Operations Division / Office of Diversion Control
  • 215. Inves9ga9ng  Pharmacies   • Arrests/Indictments • Seized Assets • Civil Fines •  Civil fines are payable to the Department of Justice and are not subject to asset sharing • Registration Revocation/Suspension Orders •  Issued by Office of Chief Counsel (CCD) • Other Administrative Actions • Sentencing •  Sentencing is enhanced if wrongful death is proven and Schedule II narcotics are involved and quantified. 215   Investigative Outcomes U.S. Drug Enforcement Administration / Operations Division / Office of Diversion Control